Rash and other nonspecific skin eruption

R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT

exanthem: a widespread rash usually occurring in children but can occur in adults. An exanthem can be caused by toxins, drugs, or microorganisms, or can result from autoimmune disease. It can be contrasted with an enanthem.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R21 Cause of death: ICD-10 — R21 2 out of 7 registries used, show all original rules.	4032
4. Check minimum number of events None	4032
5. Include endpoints None	4032
6. Filter based on genotype QC (FinnGen only)	4032

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_SKIN_SUBCU_TISSUE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R2[0-3]
Name in latin: Exanthema et aliae eruptiones cutis non specificae

NAME	R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_SKIN_SUBCU_TISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R21
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R21
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Rash and other nonspecific skin eruption based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4032	2666	1366
Unadjusted period prevalence (%)	0.80	0.91	0.60
Median age at first event (years)	54.55	51.71	60.09

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3635: Matched controls
36348

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

4503599627370496.0

323.0

3633

377

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

12.0

323.0

1247

1511

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.4

165.5

986

3609

H02AB06

ATC

prednisolone; systemic

2.4

130.5

1933

11814

E0000UV

ATC

2.3

119.7

1714

10142

D07AC01

ATC

betamethasone; topical

2.3

112.3

1478

8317

D07AB08

ATC

desonide; topical

3.4

108.6

609

2054

E000001

ATC

2.4

91.7

945

4605

R20.2

ICD-10 Finland

Paraesthesia of skin

7.1

90.8

232

344

D07AC13

ATC

mometasone; topical

2.2

88.5

1214

6768

R06AE07

ATC

cetirizine; oral

1.9

77.9

1705

11335

D07AD01

ATC

clobetasol; topical

2.4

72.5

699

3237

R4110

NOMESCO Finland

Physiotherapy

2.0

67.5

1050

6029

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

65.5

1130

6742

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.8

64.7

465

1814

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.5

62.1

567

2532

XQ800

NOMESCO Finland

Prick test

3.0

61.3

392

1414

A02BC02

ATC

pantoprazole; systemic

1.8

58.2

2286

17761

J01DB01

ATC

cefalexin; oral

1.9

57.4

2928

24758

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

57.4

1066

6471

H02AB07

ATC

prednisone; oral

2.3

56.7

595

2839

R06AX27

ATC

desloratadine; oral

1.9

56.6

1057

6422

XQ802

NOMESCO Finland

Epicutan test

4.0

56.3

238

623

L57.0

ICD-10 Finland

Actinic keratosis

2.8

55.3

384

1458

J01MA02

ATC

ciprofloxacin; systemic

1.8

53.2

1378

9304

L04AX01

ATC

azathioprine; systemic

3.7

52.1

239

671

J01DA01

ATC

[U] cefalexin; systemic

1.7

49.6

2224

17534

ZXA00

NOMESCO Finland

Right side

1.9

49.3

973

5971

ZXA05

NOMESCO Finland

Left side

1.9

49.3

928

5605

N02AX02

ATC

tramadol; systemic, rectal

1.7

49.0

1450

10126

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

48.9

1188

7805

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

47.9

492

2310

D07AA02

ATC

hydrocortisone; topical

2.2

47.9

567

2845

N03AX16

ATC

pregabalin; oral

1.9

46.8

845

5014

ZX120

NOMESCO Finland

Intravenous

2.5

46.8

405

1742

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

45.7

1266

8619

J01FF01

ATC

clindamycin; systemic

1.8

45.7

969

6068

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.7

45.5

327

1263

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.1

43.3

529

2683

R06AE09

ATC

levocetirizine; oral

2.1

43.0

578

3050

UJF32

NOMESCO Finland

Coloscopy

1.8

42.9

891

5518

J02AC01

ATC

fluconazole; systemic

1.7

42.8

1478

10658

A02BC05

ATC

esomeprazole; systemic

1.7

42.1

1397

9948

TQW99

NOMESCO Finland

Other minor procedure on skin

3.3

41.8

219

683

P01BA02

ATC

hydroxychloroquine; oral

2.5

41.3

360

1550

S29

ICPC

Skin symptom/complaint other

2.0

40.8

617

3406

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

40.5

639

3584

R50.9

ICD-10 Finland

Fever, unspecified

2.1

40.5

538

2820

M79.6

ICD-10 Finland

Pain in limb

1.7

40.2

1220

8448

E000002

ATC

2.2

39.7

464

2302

J05AB01

ATC

aciclovir; systemic

1.8

39.6

772

4662

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

38.8

943

6108

S18

ICPC

Laceration/cut

1.6

38.2

1400

10160

J01FA10

ATC

azithromycin; systemic

1.6

37.5

2028

16194

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

37.1

1432

10511

T78.4

ICD-10 Finland

Allergy, unspecified

3.1

36.2

215

733

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

36.1

563

3131

L04AD01

ATC

ciclosporin; systemic

5.3

36.0

113

219

Z71.8

ICD-10 Finland

Other specified counselling

1.7

35.3

829

5287

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

35.1

1391

10233

D06BX01

ATC

metronidazole; topical

2.1

33.5

407

2046

L30.8

ICD-10 Finland

Other specified dermatitis

4.5

33.2

120

271

D07CC01

ATC

betamethasone and antibiotics; topical

2.0

33.1

475

2553

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.7

32.9

231

876

J05AB11

ATC

valaciclovir; oral

2.0

32.5

474

2559

D02AX

ATC

Other emollients and protectives

3.2

32.3

175

560

L50.3

ICD-10 Finland

Dermatographic urticaria

5.2

32.0

101

197

R51.80

ICD-10 Finland

Headache

1.9

31.8

522

2947

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

31.6

786

5075

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

31.5

827

5422

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

31.3

813

5316

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.3

30.8

164

518

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

30.8

368

1830

L50.9

ICD-10 Finland

Urticaria, unspecified

3.2

30.7

166

531

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.4

30.4

270

1168

M25.5

ICD-10 Finland

Pain in joint

1.6

30.2

953

6557

R03DC03

ATC

montelukast; oral

1.8

30.1

570

3373

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

29.9

567

3359

A46

ICD-10 Finland

Erysipelas

1.9

29.8

455

2497

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6.0

29.7

140

C01CA24

ATC

epinephrine; parenteral

2.5

29.7

251

1057

L04AA01

ATC

[U] ciclosporin; systemic

5.2

29.6

181

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

29.6

375

1914

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

29.6

423

2265

J01MA12

ATC

levofloxacin; systemic

1.8

29.6

619

3784

WX002

NOMESCO Finland

Sedation and analgesia

1.7

29.5

675

4239

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

29.5

1453

11107

E000006

ATC

2.3

29.3

290

1324

A02BC03

ATC

lansoprazole; oral

1.6

28.9

963

6705

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

28.6

570

3428

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.1

28.6

115

289

J01FA06

ATC

roxithromycin; oral

1.5

28.5

1355

10252

J04BA02

ATC

dapsone; oral

13.8

28.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

28.4

612

3768

J01AA02

ATC

doxycycline; systemic

1.5

27.6

2638

23087

R4120

NOMESCO Finland

Occupational therapy

2.4

27.0

243

1059

D02AE01

ATC

carbamide; topical

2.3

26.9

261

1178

L20.0

ICD-10 Finland

Besnier prurigo

2.3

26.7

265

1210

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.6

460

2633

A02BC01

ATC

omeprazole; systemic

1.6

26.6

906

6319

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

26.5

318

1585

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

26.3

591

3679

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

26.2

735

4873

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

26.0

340

1755

P01AB01

ATC

metronidazole; oral, rectal

1.5

25.9

1319

10069

R60.0

ICD-10 Finland

Localized oedema

2.0

25.9

371

1983

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

25.9

166

597

H02AB04

ATC

methylprednisolone; systemic

1.8

25.8

495

2934

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

25.7

226

970

R03AC02

ATC

salbutamol; inhalant

1.5

25.7

1747

14143

R06.0

ICD-10 Finland

Dyspnoea

1.6

25.6

795

5412

E000003

ATC

2.6

25.5

197

788

L93.0

ICD-10 Finland

Discoid lupus erythematosus

9.0

25.4

D07XC01

ATC

betamethasone, combinations; topical

1.9

25.4

398

2200

L04AA06

ATC

mycophenolic acid; systemic

4.8

25.3

183

D07AC14

ATC

methylprednisolone aceponate; topical

2.7

25.3

185

718

R01AD09

ATC

mometasone; nasal

1.5

25.3

1493

11739

R03BA02

ATC

budesonide; inhalant

1.7

25.1

606

3852

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.4

24.8

224

979

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

24.7

324

1671

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

24.7

932

6644

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

24.7

342

1805

M54.5

ICD-10 Finland

Low back pain

1.5

24.6

1050

7692

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

24.5

540

3339

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

24.5

839

5841

C07AB07

ATC

bisoprolol; oral

1.4

24.0

1445

11365

G44.2

ICD-10 Finland

Tension-type headache

1.8

24.0

445

2604

C03CA01

ATC

furosemide; systemic

1.6

23.9

836

5844

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

23.8

682

4534

R05

ICD-10 Finland

Cough

1.6

23.8

632

4117

N06AX21

ATC

duloxetine; oral

1.9

23.7

362

1980

L82

ICD-10 Finland

Seborrhoeic keratosis

1.8

23.7

491

2975

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

23.7

671

4450

L30.3

ICD-10 Finland

Infective dermatitis

3.1

23.5

136

457

J01MA14

ATC

moxifloxacin; systemic

2.0

23.5

300

1530

L28

ICPC

Limited function/disability (L)

1.7

23.5

492

2994

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

23.4

361

1983

N02BE01

ATC

paracetamol; systemic, rectal

1.5

23.3

2918

26426

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

23.2

203

872

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.1

709

4795

B01AB05

ATC

enoxaparin; parenteral

1.5

23.0

962

6999

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

23.0

1472

11689

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

22.9

300

1544

R53

ICD-10 Finland

Malaise and fatigue

1.6

22.8

659

4384

A07AA02

ATC

nystatin; oral

2.2

22.7

231

1069

ZXA10

NOMESCO Finland

Bilateral

1.6

22.6

618

4052

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

22.5

718

4897

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

22.5

348

1911

R06AX22

ATC

ebastine; oral

1.6

22.4

581

3757

M03BX02

ATC

tizanidine; oral

1.4

22.3

1996

16832

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.6

22.3

102

288

J01AA04

ATC

lymecycline; systemic

1.8

22.2

446

2675

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

22.1

1069

8012

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

4.7

22.0

161

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

22.0

475

2912

N03AX12

ATC

gabapentin; oral

1.7

21.9

482

2971

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

21.8

670

4525

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.7

21.8

151

571

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

21.8

168

675

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

21.7

453

2746

A28

ICPC

Limited function/disability NOS

1.7

21.6

447

2702

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

21.4

468

2879

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.5

21.0

169

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.6

20.7

L17

ICPC

Foot/toe symptom/complaint

1.5

20.7

806

5752

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

20.6

739

5173

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

20.5

377

2197

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.6

20.3

263

E000007

ATC

2.2

20.3

217

1026

R42

ICD-10 Finland

Dizziness and giddiness

1.6

20.3

664

4544

J01CA04

ATC

amoxicillin; systemic

1.4

20.3

2749

24777

D07BC01

ATC

betamethasone and antiseptics; topical

1.8

20.3

382

2243

D69.0

ICD-10 Finland

Allergic purpura

6.3

20.3

N05CF01

ATC

zopiclone; oral

1.5

20.0

1003

7536

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.5

20.0

160

655

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

20.0

178

772

L29.9

ICD-10 Finland

Pruritus, unspecified

3.4

19.9

294

A02BA02

ATC

ranitidine; systemic

1.6

19.9

614

4144

S21

ICPC

Skin texture symptom/complaint

1.7

19.7

402

2415

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

19.6

353

2040

J01FA09

ATC

clarithromycin; systemic

1.4

19.5

1025

7764

K30

ICD-10 Finland

Functional dyspepsia

1.8

19.5

342

1961

L50.0

ICD-10 Finland

Allergic urticaria

3.1

19.4

107

349

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

19.4

246

1252

J02AC02

ATC

itraconazole; systemic

1.6

19.4

594

3996

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

19.3

139

537

ZXC50

NOMESCO Finland

Cryotherapy

3.2

19.2

104

335

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

19.0

290

1584

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.3

18.9

N06AA09

ATC

amitriptyline; systemic

1.8

18.9

328

1874

N02AA05

ATC

oxycodone; systemic

1.7

18.8

428

2660

L50.8

ICD-10 Finland

Other urticaria

3.6

18.8

234

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

18.7

241

1236

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

18.5

166

722

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

2.9

18.5

115

408

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.9

18.4

112

390

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.6

18.3

142

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

18.3

670

4698

TQW80

NOMESCO Finland

Local dermatologic skincare

3.0

18.2

105

353

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

18.2

144

588

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

18.2

142

573

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

18.2

325

1872

A01AB09

ATC

miconazole; local oral

1.9

18.1

297

1662

WX110

NOMESCO Finland

Local anesthesy

1.4

18.1

2251

19729

Z50.1

ICD-10 Finland

Other physical therapy

2.2

18.1

189

886

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

18.0

491

3204

127

Kela drug reimbursment

Transplant complication

4.3

18.0

154

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

11.5

18.0

L43.9

ICD-10 Finland

Lichen planus, unspecified

3.5

17.9

238

L92.0

ICD-10 Finland

Granuloma annulare

8.4

17.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

17.9

1136

8889

J01AA07

ATC

tetracycline; systemic

1.6

17.8

501

3295

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

17.7

260

1400

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

17.7

686

4864

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

17.7

231

1187

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

17.7

225

1147

N05BB01

ATC

hydroxyzine; systemic

2.0

17.6

224

1143

R01AD08

ATC

fluticasone; nasal

1.4

17.5

904

6803

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

17.4

161

710

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.9

17.4

105

363

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

17.4

227

1169

D06BB10

ATC

imiquimod; topical

2.3

17.4

158

693

C84.0

ICD-10 Finland

Mycosis fungoides

24.1

17.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

17.1

241

1277

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.9

17.0

104

364

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

16.9

256

1394

D86.3

ICD-10 Finland

Sarcoidosis of skin

11.2

16.7

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

16.6

349

2116

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.6

260

1431

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

16.6

508

3411

L04AB04

ATC

adalimumab; parenteral

3.2

16.5

276

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

16.5

599

4182

XX9XT

NOMESCO Finland

Other radiological intervention

27.6

16.5

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

8.3

16.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

16.4

285

1628

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

16.3

1153

9161

ZZR00

NOMESCO Finland

Flap of skin

3.2

16.3

263

AA1AD

NOMESCO Finland

CT of head and brain

1.5

16.2

680

4896

J45

ICD-10 Finland

Asthma

1.8

16.2

316

1873

N06AX11

ATC

mirtazapine; oral

1.4

16.1

971

7496

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

16.1

496

3332

XQ848

NOMESCO Finland

Dermatological photography

2.9

16.1

333

JN4BD

NOMESCO Finland

Extensive body CT

1.7

16.1

327

1964

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

16.0

303

1778

XF404

NOMESCO Finland

Ambulatory ECG

1.8

16.0

283

1627

B07.9

ICD-10 Finland

Verruca simplex

2.6

16.0

120

478

J45.8

ICD-10 Finland

Mixed asthma

2.6

15.9

114

441

A07EC02

ATC

mesalazine; oral, rectal

2.1

15.9

185

910

A01AB04

ATC

amphotericin B; local oral

2.2

15.8

166

780

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

15.8

294

1717

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

15.8

504

3413

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.8

326

1967

ZXC20

NOMESCO Finland

Use of chemical agents

3.4

15.7

232

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

15.7

333

2024

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

15.6

186

923

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

15.6

382

2416

L71.9

ICD-10 Finland

Rosacea, unspecified

3.0

15.6

298

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

15.5

200

1024

X57

ICD-10 Finland

Unspecified privation

3.0

15.5

299

UJH02

NOMESCO Finland

Anoscopy

2.3

15.5

146

654

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.4

15.5

130

H02AB09

ATC

hydrocortisone; systemic

2.9

15.4

342

D01AC02

ATC

miconazole; topical

1.9

15.4

239

1312

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

15.4

210

1102

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

15.4

1258

10215

ZQZ00

NOMESCO Finland

Treatment of several skin areas

7.7

15.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

15.3

211

R52.9

ICD-10 Finland

Pain, unspecified

1.8

15.3

262

1489

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

15.3

187

938

M04AA01

ATC

allopurinol; systemic

1.7

15.2

339

2088

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

15.2

553

3859

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.6

15.1

192

XA402

NOMESCO Finland

ENMG

2.8

15.1

358

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

15.1

423

2775

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

15.0

207

1090

KMAK

NOMESCO Finland

1.3

15.0

1639

13891

R06AX13

ATC

loratadine; oral

1.5

14.9

481

3260

A04AA01

ATC

ondansetron; systemic, rectal

1.9

14.8

219

1185

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

14.7

212

1133

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

14.7

241

1352

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

14.6

202

1065

R03BA01

ATC

beclometasone; inhalant

1.6

14.5

435

2897

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.9

14.5

314

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

3.0

14.5

286

WW200

NOMESCO Finland

Immunization

2.6

14.4

105

410

UKC02

NOMESCO Finland

Cystoscopy

1.6

14.4

442

2962

L73.8

ICD-10 Finland

Other specified follicular disorders

5.0

14.4

L30.0

ICD-10 Finland

Nummular dermatitis

2.4

14.4

119

500

XKD00

NOMESCO Finland

Uroflowmetry

1.6

14.4

396

2585

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

14.4

189

977

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.6

14.3

102

396

A06AD11

ATC

lactulose; oral

1.6

14.3

408

2685

R05

ICPC

Cough

1.4

14.3

688

5083

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

4.1

14.2

132

L03AA02

ATC

filgrastim; parenteral

2.8

14.2

336

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

14.2

950

7445

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

14.1

177

898

R03AC03

ATC

terbutaline; inhalant

1.6

14.1

435

2917

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

7.7

14.1

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

14.0

148

700

R01AD12

ATC

fluticasone furoate; nasal

1.4

13.9

907

7068

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

13.9

362

2330

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.0

13.9

135

D01

ICPC

Abdominal pain/cramps general

1.6

13.8

333

2097

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

13.8

224

1253

L12.0

ICD-10 Finland

Bullous pemphigoid

6.0

13.7

M02AA07

ATC

piroxicam; topical

1.3

13.7

1120

9047

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.7

1617

13792

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

13.7

295

1800

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

9.1

13.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

13.6

110

455

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

13.6

469

3228

R06AX26

ATC

fexofenadine; oral

1.9

13.6

201

1086

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.4

13.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

13.5

250

1455

R35

ICD-10 Finland

Polyuria

2.0

13.5

176

907

A29

ICPC

General symptom/complaint other

1.6

13.5

331

2095

L43.8

ICD-10 Finland

Other lichen planus

3.2

13.4

228

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

13.4

545

3885

L29

ICPC

Musculoskeletal sympt/complt other

1.8

13.3

231

1319

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

13.3

577

4171

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

13.3

161

805

N05BA04

ATC

oxazepam; oral

1.4

13.2

749

5692

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.8

13.2

142

L04AB01

ATC

etanercept; parenteral

3.4

13.1

189

R07.0

ICD-10 Finland

Pain in throat

1.9

13.0

189

1014

J01DA06

ATC

[U] cefuroxime; systemic

1.5

13.0

442

3028

L95.8

ICD-10 Finland

Other vasculitis limited to skin

8.3

13.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.0

403

2706

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

13.0

337

2165

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.4

13.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

12.9

316

2000

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

12.9

382

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.2

12.8

116

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.3

12.8

N06AX16

ATC

venlafaxine; oral

1.5

12.7

412

2794

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

3.6

12.6

158

R21

ICPC

Throat symptom/complaint

1.4

12.5

595

4373

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.5

842

6582

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

8.7

12.5

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.5

430

2955

M05BA04

ATC

alendronic acid; oral

1.7

12.4

244

1452

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

12.3

171

902

A12AA04

ATC

calcium carbonate; oral

3.5

12.3

161

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

12.3

143

704

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

12.3

117

530

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

14.4

12.2

L03

ICPC

Low back symptom/complaint

1.4

12.2

708

5389

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.0

12.2

122

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

12.1

250

1507

L12

ICPC

Hand/finger symptom/complaint

1.5

12.1

422

2907

WW500

NOMESCO Finland

Blood transfusion

2.2

12.1

126

594

L71.8

ICD-10 Finland

Other rosacea

3.3

12.1

185

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.7

12.1

298

ZX112

NOMESCO Finland

Subcutaneous

2.8

12.1

268

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.1

1180

9747

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.0

12.0

157

812

RD210

NOMESCO Finland

2.8

12.0

282

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

4.2

12.0

105

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

3.1

12.0

208

XQ820

NOMESCO Finland

Exposure to medicinal substance

8.7

12.0

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

12.0

845

6643

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

10.1

12.0

XX9XE

NOMESCO Finland

Other ultrasound examination

4.3

11.9

101

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.6

11.9

150

A07EA06

ATC

budesonide; oral, local oral

2.3

11.9

108

476

N06AB04

ATC

citalopram; systemic

1.4

11.8

647

4876

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

11.8

2243

20215

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.8

240

1439

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.8

1661

14399

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

11.8

250

1518

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

11.7

145

734

A03FA02

ATC

cisapride; oral, rectal

1.7

11.7

225

1330

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

11.6

247

1501

N05BA01

ATC

diazepam; systemic, rectal

1.5

11.6

399

2739

S97

ICPC

Chronic ulcer skin

2.0

11.6

155

807

J01MA06

ATC

norfloxacin; oral

1.5

11.6

420

2920

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

11.5

408

2818

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

11.5

126

605

D05BB02

ATC

acitretin; oral

2.7

11.5

289

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.8

11.5

124

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.5

11.5

357

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

11.4

298

1916

RJ412

NOMESCO Finland

13.6

11.4

R5599

NOMESCO Finland

Other rehabilitation service

2.4

11.4

379

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

11.3

177

978

R01AD01

ATC

beclometasone; nasal

1.5

11.2

446

3160

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

3.2

11.2

185

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

11.2

116

544

H93.1

ICD-10 Finland

Tinnitus

1.8

11.2

185

1041

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.2

395

2730

C08CA01

ATC

amlodipine; oral

1.3

11.1

975

7914

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.2

11.0

176

R74

ICPC

Upper respiratory infection acute

1.3

11.0

840

6674

J01EA01

ATC

trimethoprim; systemic

1.3

11.0

796

6272

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.6

11.0

304

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

11.0

127

628

L04AA13

ATC

leflunomide; oral

2.5

10.9

359

G72.9

ICD-10 Finland

Myopathy, unspecified

5.0

10.9

N03AF01

ATC

carbamazepine; oral, rectal

1.9

10.9

150

793

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

10.9

104

471

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

10.9

226

1364

A07EA02

ATC

hydrocortisone; rectal

2.6

10.8

301

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

10.8

239

1472

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.8

10.8

240

S76

ICPC

Skin infection other

2.0

10.7

138

709

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

10.7

396

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

10.7

105

480

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.7

832

6627

R2110

NOMESCO Finland

Giving the first information

1.7

10.7

218

1311

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

10.7

134

684

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

10.7

164

901

A11CC03

ATC

alfacalcidol; systemic

2.7

10.7

273

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

10.7

418

L04AA11

ATC

[U] etanercept; parenteral

6.7

10.6

M01AH02

ATC

rofecoxib; oral

1.5

10.6

379

2623

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

10.6

574

4305

ZXC10

NOMESCO Finland

Use of laser

2.6

10.6

298

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

10.6

251

D01AE15

ATC

terbinafine; topical

1.8

10.5

189

1094

A04

ICPC

Weakness/tiredness general

1.5

10.5

368

2537

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

10.5

261

K90.0

ICD-10 Finland

Coeliac disease

2.3

10.5

426

Z01.7

ICD-10 Finland

Laboratory examination

1.5

10.5

321

2146

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

10.5

277

1785

M01AB05

ATC

diclofenac; systemic, rectal

1.3

10.5

2059

18486

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

10.5

300

1976

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

10.4

173

974

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

10.4

1678

14706

M01AH05

ATC

etoricoxib; oral

1.3

10.4

1787

15780

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.4

646

4965

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

10.4

568

4274

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

10.3

218

1324

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.5

10.3

309

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

10.3

301

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

9.6

10.2

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.5

10.2

322

D11

ICPC

Diarrhoea

1.5

10.2

313

2097

N03AX09

ATC

lamotrigine; oral

1.9

10.1

140

742

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.1

1459

12602

TAB00

NOMESCO Finland

Lumbar puncture

2.0

10.1

127

649

M79.1

ICD-10 Finland

Myalgia

1.5

10.1

361

2498

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

10.1

188

1100

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.9

10.1

104

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.1

10.0

178

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

10.0

255

1630

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

10.0

261

1676

D01BA02

ATC

terbinafine; oral; topical

1.3

10.0

681

5305

Z01.2

ICD-10 Finland

Dental examination

1.3

10.0

1249

10595

R52.0

ICD-10 Finland

Acute pain

2.2

10.0

430

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.6

10.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

9.9

341

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

9.9

277

1810

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.8

210

1281

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.7

9.8

232

C05AA08

ATC

fluocortolone; rectal, topical

1.5

9.8

402

2860

N06AB06

ATC

sertraline; oral

1.5

9.8

313

2112

U02

ICPC

Urinary frequency/urgency

1.5

9.8

395

2804

L01BB01

ATC

10.6

9.8

M35.7

ICD-10 Finland

Hypermobility syndrome

3.2

9.8

154

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

4.5

9.7

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

9.7

210

1283

R13

ICD-10 Finland

Dysphagia

1.8

9.7

176

1023

B01AB10

ATC

tinzaparin; parenteral

1.7

9.7

200

1207

D29

ICPC

Digestive symptom/complaint other

2.9

9.7

199

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

9.7

313

2119

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

3.3

9.6

145

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

9.6

426

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.0

9.6

116

582

K07.60

ICD-10 Finland

Snapping jaw

1.9

9.6

143

778

Z94.0

ICD-10 Finland

Kidney transplant status

3.9

9.6

M01AX17

ATC

nimesulide; oral

1.3

9.5

701

5524

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

9.5

799

6421

H92.0

ICD-10 Finland

Otalgia

1.8

9.5

148

817

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.5

9.5

120

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.1

9.5

163

WZA90

NOMESCO Finland

Other doctors statement

1.3

9.5

658

5137

M79.7

ICD-10 Finland

Fibromyalgia

2.1

9.5

100

477

L60.0

ICD-10 Finland

Ingrowing nail

1.9

9.5

126

658

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

9.5

157

885

M48.0

ICD-10 Finland

Spinal stenosis

1.5

9.4

310

2106

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

9.4

355

2485

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

5.1

9.4

K50.8

ICD-10 Finland

Other Crohn disease

2.9

9.3

186

J01FA01

ATC

erythromycin; systemic

1.4

9.3

413

2985

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.9

9.3

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.9

9.3

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.3

209

1294

L29.8

ICD-10 Finland

Other pruritus

3.2

9.3

144

D06BB03

ATC

aciclovir; topical

1.9

9.3

142

779

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

9.2

182

1085

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

9.2

338

2354

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.1

9.2

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

9.2

347

2428

N05AH04

ATC

quetiapine; oral

1.4

9.2

450

3314

1XC02

NOMESCO Finland

4.4

9.2

J01DC02

ATC

cefuroxime; systemic

1.8

9.2

162

935

B02

ICD-10 Finland

Zoster [herpes zoster]

2.1

9.1

104

511

E000004

ATC

2.5

9.1

278

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

9.1

162

936

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

9.1

255

1670

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

9.1

165

957

R01AD05

ATC

budesonide; nasal

1.6

9.1

225

1426

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.3

9.1

135

EB1AA

SPAT

1.9

9.1

137

751

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.3

9.0

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.5

9.0

115

D10AF01

ATC

clindamycin; topical

1.8

9.0

144

804

D05AX02

ATC

calcipotriol; topical

2.0

9.0

114

585

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

9.0

107

534

J02AB02

ATC

ketoconazole; oral

2.2

9.0

393

L01

ICPC

Neck symptom/complaint

1.4

9.0

376

2689

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.5

8.9

276

L30.4

ICD-10 Finland

Erythema intertrigo

3.5

8.9

111

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

8.9

251

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

8.9

174

RJ420

NOMESCO Finland

6.1

8.9

C08CA05

ATC

nifedipine; systemic

1.7

8.9

175

1042

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

5.7

8.9

TK800

NOMESCO Finland

Hemodialysis

2.7

8.9

227

D05AX52

ATC

calcipotriol, combinations; topical

1.8

8.9

150

853

C07AB02

ATC

metoprolol; systemic

1.4

8.8

559

4301

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.8

148

838

EB1WA

NOMESCO Finland

4.8

8.8

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

4.9

8.8

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

8.6

8.8

M01AC06

ATC

meloxicam; systemic, rectal

1.3

8.8

1066

8978

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

8.8

351

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.0

8.7

162

A11

ICPC

Chest pain NOS

1.6

8.7

195

1209

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

8.6

126

684

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

8.6

166

985

G47.3

ICD-10 Finland

Sleep apnoea

1.4

8.6

544

4182

R02

ICPC

Shortness of breath/dyspnoea

1.5

8.6

330

2318

L02

ICPC

Back symptom/complaint

1.6

8.6

246

1620

-60

ICPC

Result test/procedure

1.7

8.6

176

1063

G04CA02

ATC

tamsulosin; oral

1.4

8.6

484

3655

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

8.6

253

1677

L98.6

ICD-10 Finland

Other infiltrative disorders of skin and subcutaneous tissue

16.3

8.5

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.5

247

1633

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

8.5

158

925

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

8.5

165

980

B01AB04

ATC

dalteparin; parenteral

1.8

8.5

136

760

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

8.5

198

RS221

NOMESCO Finland

2.8

8.5

198

R07.3

ICD-10 Finland

Other chest pain

1.5

8.5

245

1619

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

8.4

350

2497

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

8.4

226

1466

Z00.0

ICD-10 Finland

General medical examination

1.4

8.4

506

3856

L52

ICD-10 Finland

Erythema nodosum

4.0

8.4

F29

ICPC

Eye symptom/complaint other

1.6

8.4

230

1498

C07AA05

ATC

propranolol; systemic

1.3

8.4

553

4279

A60

ICPC

General and Unspecified, Result test/procedure

1.9

8.4

125

682

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

8.3

185

1140

A07DA03

ATC

loperamide; oral

2.0

8.3

489

Q82.80

ICD-10 Finland

Benign familial pemphigus [Hailey-Hailey]

+∞

8.3

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

8.3

373

S02

ICPC

Pruritus

2.0

8.3

102

518

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.3

371

2689

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

5.8

8.3

R03BA08

ATC

ciclesonide; inhalant

1.6

8.3

227

1479

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.0

8.2

146

M10.0

ICD-10 Finland

Idiopathic gout

2.2

8.2

354

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.2

8.2

124

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

8.2

200

1264

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.0

8.2

106

551

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

8.2

1156

9895

N05BA12

ATC

alprazolam; oral

1.5

8.2

288

1988

ZXC12

NOMESCO Finland

Pulse colorlaser

6.5

8.2

U13

ICPC

Bladder symptom/complaint other

2.1

8.2

451

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

8.1

116

625

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

8.1

112

596

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

8.1

287

K96

ICPC

Haemorrhoids

2.3

8.1

319

N30

ICD-10 Finland

Cystitis

1.6

8.1

213

1377

WX892

NOMESCO Finland

Monitored bed care

1.6

8.1

202

1289

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

8.1

109

575

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

8.1

105

547

L08.0

ICD-10 Finland

Pyoderma

3.6

8.0

UJD02

NOMESCO Finland

Gastroscopy

1.8

8.0

124

684

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.0

696

5603

L41.1

ICD-10 Finland

Pityriasis lichenoides chronica

22.1

8.0

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.0

8.0

D19

ICPC

Teeth/gum symptom/complaint

1.3

8.0

743

6036

XCK00

NOMESCO Finland

Perimetry

1.6

8.0

185

1156

C03DA01

ATC

spironolactone; oral

1.5

8.0

274

1881

L04AA17

ATC

[U] adalimumab; parenteral

5.9

8.0

WX110

SPAT

1.8

8.0

126

704

SBB10

NOMESCO Finland

Teeth copy

1.6

8.0

188

1183

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

7.9

276

A08

ICPC

Swelling

1.9

7.9

118

645

N01

ICPC

Headache

1.5

7.9

295

2062

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

7.9

327

R04.0

ICD-10 Finland

Epistaxis

1.6

7.9

181

1128

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.9

192

1214

J30.3

ICD-10 Finland

Other allergic rhinitis

2.0

7.9

494

SXC03

NOMESCO Finland

Other oral or dental procedure

3.2

7.9

123

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.5

7.9

222

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

7.9

220

1443

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

6.6

7.9

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.9

1723

15440

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

7.9

185

1159

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

7.9

204

1312

C09CA01

ATC

losartan; oral

1.3

7.9

637

5078

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

7.8

143

835

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.8

7.8

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.0

7.8

141

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

10.8

7.8

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.8

790

6491

DHB00

NOMESCO Finland

Excision of lesion of external nose

3.4

7.8

103

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

7.8

156

936

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

7.8

427

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

7.8

308

2178

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

7.7

189

1200

R29

ICPC

Respiratory symptom/complaint other

1.6

7.7

171

1057

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

3.7

7.7

R49.01

ICD-10 Finland

Functional dysphonia

2.0

7.7

455

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.1

7.7

131

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.0

7.7

137

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.7

2157

19808

R20.0

ICD-10 Finland

Anaesthesia of skin

7.4

7.7

R00.2

ICD-10 Finland

Palpitations

1.6

7.6

197

1264

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.9

7.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

7.6

239

H01.0

ICD-10 Finland

Blepharitis

1.7

7.6

153

919

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.6

1191

10293

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

7.6

107

573

M03BX01

ATC

baclofen; systemic

2.7

7.6

190

R96

ICPC

Asthma

1.5

7.6

239

1612

B03XA01

ATC

erythropoietin; parenteral

4.0

7.5

R55

ICD-10 Finland

Syncope and collapse

1.5

7.5

276

1921

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

7.5

216

1424

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

7.5

177

1110

WX890

NOMESCO Finland

Intesive care monitoring

3.9

7.5

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

6.2

7.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

7.5

482

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

3.0

7.5

139

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

7.5

509

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

7.5

227

L21.0

ICD-10 Finland

Seborrhoea capitis

3.2

7.5

117

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

7.5

106

568

-59

ICPC

Other therap proced/minor surg NEC

2.1

7.5

372

U01

ICPC

Dysuria/painful urination

1.6

7.5

209

1370

R25.2

ICD-10 Finland

Cramp and spasm

2.3

7.4

267

S15

ICPC

Foreign body in skin

1.7

7.4

160

983

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

7.4

139

817

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

7.4

557

4393

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.4

2006

18319

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.4

7.4

RS220

NOMESCO Finland

2.8

7.4

164

B02.9

ICD-10 Finland

Zoster without complication

1.7

7.4

147

882

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

7.3

496

R4190

NOMESCO Finland

Nutritional therapy

1.9

7.3

101

539

L13.9

ICD-10 Finland

Bullous disorder, unspecified

4.7

7.3

N03AE01

ATC

clonazepam; systemic

1.7

7.3

157

964

XA420

NOMESCO Finland

Extensive sleep examination

3.2

7.3

114

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

6.8

7.3

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

7.3

127

732

A98

ICPC

Health maint/preventive medicine

1.4

7.3

3344

32404

WX402

NOMESCO Finland

General anaesthesia

1.3

7.3

464

3572

R03DC01

ATC

zafirlukast; oral

2.5

7.3

208

J01FA15

ATC

telithromycin; oral

1.5

7.3

278

1954

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

7.3

204

1342

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

7.2

462

K80

ICPC

Cardiac arrhythmia NOS

1.6

7.2

193

1253

A92

ICPC

Allergy/allergic reaction NOS

2.1

7.2

399

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

7.2

297

R03BA05

ATC

fluticasone; inhalant

1.3

7.2

508

3967

TGC00

NOMESCO Finland

Bronchial lavation

2.1

7.2

352

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

7.2

414

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

7.3

7.2

M10.9

ICD-10 Finland

Gout, unspecified

1.7

7.2

144

868

A05AA02

ATC

ursodeoxycholic acid; oral

2.5

7.2

221

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

7.2

157

968

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

7.2

119

677

R52.2

ICD-10 Finland

Other chronic pain

2.0

7.2

469

D06BB04

ATC

podophyllotoxin; topical

1.7

7.2

133

781

V03AE01

ATC

polystyrene sulfonate; oral

3.3

7.1

105

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

7.1

944

7997

B01AA03

ATC

warfarin; systemic

1.3

7.1

487

3782

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.7

7.1

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

7.1

133

S04

ICPC

Lump/swelling localized

1.5

7.1

238

1629

S01

ICPC

Pain/tenderness of skin

1.8

7.1

111

619

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

7.1

298

2134

-62

ICPC

Administrative procedure

2.0

7.1

422

R03AC12

ATC

salmeterol; inhalant

1.8

7.1

122

703

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.1

107

591

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.5

7.1

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

7.1

159

986

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

7.1

254

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.0

264

1846

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.9

7.0

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

7.0

L30

ICD-10 Finland

Other dermatitis

2.3

7.0

255

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

7.0

727

5981

J46

ICD-10 Finland

Status asthmaticus

2.1

7.0

376

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

7.0

225

J20

ICD-10 Finland

Acute bronchitis

1.5

7.0

251

1742

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

7.0

173

1100

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

7.0

342

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

7.0

317

2300

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

7.0

142

858

-1

NOMESCO Finland

1.2

7.0

975

8306

D01AC03

ATC

econazole; topical

1.6

7.0

160

999

R83

ICPC

Respiratory infection other

1.3

7.0

665

5412

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

7.0

214

1436

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

7.0

289

R05FB02

ATC

cough suppressants and expectorants

1.2

7.0

1088

9380

K59.0

ICD-10 Finland

Constipation

1.7

6.9

143

865

ZX108

NOMESCO Finland

Inhalation

3.7

6.9

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

6.9

406

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.9

351

2600

XQ899

NOMESCO Finland

Other assessment of skin

6.3

6.9

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.4

6.9

239

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

6.9

138

831

K51.5

ICD-10 Finland

Left sided colitis

2.1

6.9

346

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

4.2

6.9

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

13.8

6.9

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

13.8

6.9

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

6.9

337

2484

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

6.9

198

1309

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

6.9

122

710

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.9

1593

14288

N03AX11

ATC

topiramate; oral

2.1

6.8

351

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.8

217

1467

SPAT1336

SPAT

Request for examination

1.8

6.8

107

599

A03

ICPC

Fever

1.3

6.8

433

3328

S01GX02

ATC

levocabastine; ophthalmic

1.6

6.8

171

1092

R01AD11

ATC

triamcinolone; nasal

1.5

6.8

237

1636

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.9

6.8

135

E85.9

ICD-10 Finland

Amyloidosis, unspecified

9.3

6.8

N05BE01

ATC

buspirone; oral

2.0

6.7

405

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

6.7

299

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.7

6.7

WX320

NOMESCO Finland

Spinalanesthesy

1.3

6.7

616

4987

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.7

186

1220

R5110

SPAT

2.1

6.7

322

J01XC01

ATC

fusidic acid; systemic

2.6

6.7

174

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

6.7

278

1984

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

6.7

534

ZXC15

NOMESCO Finland

Use of photodynamic technique

3.0

6.7

116

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

6.7

434

3347

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.5

6.7

199

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.3

6.7

D93

ICPC

Irritable bowel syndrome

3.0

6.7

122

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.7

6.7

120

700

ZX100

NOMESCO Finland

Oral

2.7

6.7

160

S06.0

ICD-10 Finland

Concussion

1.4

6.7

272

1938

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.7

343

2546

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.6

6.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.7

501

3947

D05AX03

ATC

calcitriol; topical

2.7

6.7

161

R51.81

ICD-10 Finland

Facial pain NOS

2.3

6.6

261

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

6.6

387

SBA00

NOMESCO Finland

Microbiological examinations

2.1

6.6

352

XG460

NOMESCO Finland

Short time oxymetry

2.5

6.6

187

EKA10

NOMESCO Finland

Biopsy of cheek

2.3

6.6

263

A02BA04

ATC

nizatidine; systemic

1.5

6.6

207

1396

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

6.6

133

800

XLA10

NOMESCO Finland

1.7

6.6

143

880

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.6

254

1788

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.6

1256

11039

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.6

517

4102

N03AG01

ATC

valproic acid; systemic, rectal

1.6

6.6

164

1048

TNG10

NOMESCO Finland

Puncture of knee

3.0

6.6

118

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.9

6.6

488

A99

ICPC

Disease/condition unspecnature/site

1.5

6.6

199

1330

L08

ICPC

Shoulder symptom/complaint

1.3

6.6

497

3923

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

6.6

251

1768

K07

ICPC

Swollen ankles/oedema

1.8

6.5

106

599

R51

ICD-10 Finland

Headache

1.7

6.5

134

811

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

6.5

825

6944

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

6.5

100

553

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

6.5

113

L98.1

ICD-10 Finland

Factitial dermatitis

10.0

6.5

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.5

6.5

182

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.1

6.5

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

6.5

127

762

R03BC03

ATC

nedocromil; inhalant

1.5

6.5

186

1231

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

6.2

6.5

ELA30

NOMESCO Finland

Biopsy of salivary gland

6.2

6.5

L04AC05

ATC

ustekinumab; parenteral

5.3

6.4

N06AB10

ATC

escitalopram; oral

1.3

6.4

543

4348

WW200

SPAT

0.6

6.4

129

1974

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

6.4

192

K60.0

ICD-10 Finland

Acute anal fissure

3.0

6.4

109

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

6.4

146

911

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

6.4

B35.3

ICD-10 Finland

Tinea pedis

1.8

6.4

536

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

6.4

506

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

6.4

553

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

6.4

307

2256

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.6

6.4

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.9

6.4

121

M54.3

ICD-10 Finland

Sciatica

1.6

6.4

152

960

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

3.7

6.4

S06

ICPC

Rash localized

1.6

6.4

144

898

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.1

6.3

297

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.3

308

2266

N02CC04

ATC

rizatriptan; oral

1.6

6.3

155

985

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.4

6.3

C10AA03

ATC

pravastatin; oral

1.6

6.3

172

1124

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.3

6.3

225

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.9

6.3

116

XQ801

NOMESCO Finland

Intracutantest

5.5

6.3

U07

ICPC

Urine symptom/complaint other

1.6

6.3

148

931

J01CF05

ATC

flucloxacillin; systemic

1.8

6.3

100

562

137

Kela drug reimbursment

Uraemia requiring dialysis

3.5

6.3

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.2

6.3

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.6

6.3

143

893

R04.2

ICD-10 Finland

Haemoptysis

1.9

6.3

430

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

6.3

138

854

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.9

6.3

488

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.7

6.2

146

L93

ICD-10 Finland

Lupus erythematosus

26.7

6.2

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

6.2

182

D10AX03

ATC

azelaic acid; topical

1.5

6.2

192

1290

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.2

1712

15549

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

6.2

354

C10AC01

ATC

colestyramine; oral

2.0

6.2

381

AN1

Coronary angiography

1.4

6.2

275

1991

N05CF02

ATC

zolpidem; oral

1.3

6.2

482

3818

H02BX01

ATC

methylprednisolone, combinations; systemic

1.6

6.2

134

825

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.6

6.2

147

928

B35.1

ICD-10 Finland

Tinea unguium

1.6

6.2

134

827

L29.0

ICD-10 Finland

Pruritus ani

3.1

6.2

101

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.1

6.2

101

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.2

442

3459

F01

ICPC

Eye pain

2.0

6.1

357

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.5

6.1

J35.2

ICD-10 Finland

Hypertrophy of adenoids

2.3

6.1

222

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

6.1

344

M79.3

ICD-10 Finland

Panniculitis, unspecified

5.7

6.1

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

6.1

615

5033

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

7.7

6.1

A01

ICPC

Pain general/multiple sites

1.5

6.1

201

1373

D07AC03

ATC

desoximetasone; topical

2.2

6.1

243

UJF30

SPAT

4.7

6.1

L60.3

ICD-10 Finland

Nail dystrophy

4.7

6.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.1

550

4442

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

12.5

6.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

6.1

154

990

K11.2

ICD-10 Finland

Sialoadenitis

1.9

6.1

459

R03BB04

ATC

tiotropium bromide; inhalant

1.4

6.0

240

1700

L13

ICPC

Hip symptom/complaint

1.3

6.0

409

3174

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

6.0

219

1527

L04AB06

ATC

golimumab; parenteral

3.3

6.0

R06AX12

ATC

terfenadine; oral

1.7

6.0

129

792

D12

ICPC

Constipation

1.9

6.0

422

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

6.0

194

1318

ZX114

NOMESCO Finland

Intramuscular

2.5

6.0

180

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

2.5

6.0

180

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

466

1324

3.85

141.72

1.3

1.2

—

(40758558) Short blood count panel - Blood

1476

8379

2.20

116.61

9.6

6.6

—

(3001604) Monocytes [#/volume] in Blood

2393

16361

2.14

116.23

9.2

5.9

0.58

e9/l

0.69

2115

14035

(3006315) Basophils [#/volume] in Blood

2398

16413

2.14

116.07

9.3

5.9

0.04

e9/l

0.32

2124

14093

(3022096) Basophils/100 leukocytes in Blood

2233

14978

2.10

112.73

9.7

6.1

0.68

0.15

2149

13953

(3019198) Lymphocytes [#/volume] in Blood

2422

16838

2.10

109.88

9.3

5.9

1.89

1.93

e9/l

0.57

2166

14780

(3006504) Eosinophils/100 leukocytes in Blood

2265

15419

2.07

108.06

9.6

6.1

3.03

2.85

2.89

2172

14349

(3013115) Eosinophils [#/volume] in Blood

2432

17018

2.08

107.31

9.7

6.1

0.20

0.19

e9/l

2.31

2174

14868

(3019069) Monocytes/100 leukocytes in Blood

2265

15508

2.05

105.27

9.8

6.3

8.76

8.53

3.15

2183

14500

(3021589) Normoblasts [#/volume] in Blood

2174

14731

2.03

103.24

13.1

9.4

0.00

e9/l

0.70

1803

11941

(3013650) Neutrophils [#/volume] in Blood by Automated count

2624

19104

2.07

101.04

12.8

8.9

4.03

4.06

e9/l

0.29

2327

16593

(3018095) Leukocytes [#/volume] in Urine

1806

11517

2.03

101.00

5.2

3.7

113.61

110.16

e6/l

0.03

1331

7990

(3018010) Neutrophils/100 leukocytes in Blood

2269

15712

2.02

100.17

9.3

5.9

57.23

56.96

0.52

2183

14674

(3018418) pH of Serum or Plasma

1562

9507

2.05

98.94

5.2

4.0

7.40

0.12

262

1841

(3002030) Lymphocytes/100 leukocytes in Blood

2290

15956

2.01

98.76

9.7

6.1

27.94

28.32

0.94

2203

14857

(3002582) Erythrocytes [#/volume] in Urine

1568

9725

2.00

92.72

4.4

3.2

55.60

85.76

e6/l

0.59

1247

7391

(42870588) Differential panel, method unspecified - Blood

1718

11173

1.94

86.93

8.4

6.0

—

(3037522) Nuclear Ab [Titer] in Serum

857

4357

2.23

84.94

1.6

1.3

644.68

576.82

titre

0.43

205

925

(3033658) Prothrombin time (PT) actual/Normal

1351

8247

1.96

81.19

4.9

3.9

91.31

91.16

0.07

1321

8026

(3030467) Casts [#/volume] in Urine by Automated count

1408

8945

1.88

73.35

4.2

3.1

0.32

0.43

e6/l

0.85

1095

6692

(36304419) Bacteria [Presence] in Urine

1381

8727

1.89

73.09

4.2

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

923

5084

2.06

73.04

3.5

2.9

3.30

2.95

e6/l

0.43

546

2699

(3015171) Extractable nuclear Ab [Units/volume] in Serum

348

1264

2.92

69.65

1.4

1.3

0.30

1.36

u/ml

2.09

111

(3002385) Erythrocyte distribution width [Ratio]

3304

27656

2.08

68.54

26.5

16.7

13.78

13.67

3.91

3264

27048

(3000850) Epithelial cells [#/volume] in Urine

1119

6773

1.90

66.48

3.5

2.6

5.01

6.16

e6/l

2.62

981

5915

(40768804) Tissue Pathology biopsy report

1871

13294

1.76

65.03

2.5

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

526

2416

2.35

65.03

3.5

2.7

10.56

10.48

g/l

0.15

497

2216

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

227

688

3.44

61.55

1.5

1.2

43.75

42.67

u/ml

0.03

(3026782) Osmolality of Urine

1046

6329

1.88

61.43

3.7

2.7

526.55

540.93

mosm/kgh2o

1.37

901

5387

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2006

14698

1.73

61.15

7.3

6.1

1.22

1.21

mmol/l

0.96

1886

13296

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

283

997

2.98

59.66

2.1

1.7

1.16

1.18

g/l

0.74

269

941

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3037

25109

1.85

59.63

10.2

7.3

79.20

78.96

u/l

0.10

2924

23605

(3013707) Erythrocyte sedimentation rate by Westergren method

2970

24408

1.82

59.23

6.0

4.0

13.19

12.18

mm/h

3.30

2835

22578

(3024561) Albumin [Mass/volume] in Serum or Plasma

1907

13916

1.70

57.86

6.0

4.8

35.38

35.56

g/l

0.74

1794

12921

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

604

3072

2.14

57.84

2.5

2.3

36.40

54.85

u/l

0.61

521

2619

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

272

969

2.94

56.15

2.3

1.7

0.23

0.24

g/l

1.00

259

914

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2139

16196

1.68

55.65

8.0

6.7

1.22

mmol/l

0.39

1870

13650

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1533

10636

1.71

55.36

4.0

3.2

39.79

33.41

u/l

0.28

1470

10100

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

909

5419

1.87

55.08

3.4

2.7

1.05

1.26

e6/l

0.59

534

3020

(3023420) DNA double strand Ab [Units/volume] in Serum

141

345

4.20

52.00

2.3

1.5

51.36

25.11

iu/ml

0.80

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1875

13896

1.65

51.51

2.8

2.3

77.80

77.71

nmol/l

0.05

1746

12507

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

675

3734

1.97

50.84

3.6

2.8

6.73

8.06

umol/l

0.95

582

3225

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2168

16758

1.64

49.65

7.2

6.1

10.84

11.26

umol/l

0.81

2081

15821

(3005322) IgE [Units/volume] in Serum or Plasma

438

2090

2.23

48.81

1.5

1.3

417.88

200.77

u/ml

1.94

411

1931

(3007164) IgA [Mass/volume] in Serum or Plasma

1030

6598

1.75

48.24

1.6

1.4

2.40

2.37

g/l

0.21

624

3949

(3023368) Bacteria identified in Blood by Culture

1256

8535

1.68

47.25

5.5

4.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

406

1912

2.25

46.63

2.0

1.8

1.18

1.33

g/l

1.01

389

1748

(3039162) Centromere protein B Ab [Units/volume] in Serum

148

413

3.68

45.43

1.4

1.3

61.75

49.85

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

2069

16033

1.60

45.11

6.0

4.9

0.00

estimate

0.80

421

3052

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

244

923

2.75

44.91

1.5

1.2

38.24

49.37

u/ml

0.24

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

232

858

2.81

44.58

1.5

1.3

17.02

8.29

u/ml

0.44

139

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

230

847

2.82

44.55

1.5

1.2

27.12

7.15

u/ml

0.57

(3035350) Ketones [Presence] in Urine by Test strip

2057

15980

1.59

43.89

4.5

3.6

0.00

estimate

0.50

402

3001

(3031040) Bacteria [#/volume] in Urine by Automated count

2645

21823

1.62

43.52

5.9

4.4

730.67

1937.53

e6/l

1.00

101

294

(3009261) Glucose [Presence] in Urine by Test strip

2076

16209

1.58

42.99

4.5

3.7

0.00

estimate

1.32

416

2992

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

100

218

4.68

42.71

1.3

1.5

21.07

19.28

u/ml

0.15

(3007853) Bacteria identified in Skin by Aerobe culture

646

3725

1.87

42.30

2.1

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1192

8197

1.64

41.78

3.1

2.6

3151.01

5271.88

umol/l

1.22

1076

7101

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1738

13106

1.57

41.29

2.2

2.0

95.37

95.78

pmol/l

0.14

907

6676

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1901

14646

1.56

41.00

3.5

2.8

124.91

115.19

ug/l

0.52

1779

13557

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

231

892

2.69

40.81

2.0

2.3

0.00

0.01

g/l

0.55

215

821

(3009445) Proteinase 3 Ab [Units/volume] in Serum

292

1262

2.42

40.77

1.6

1.5

9.34

18.08

u/ml

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

713

4289

1.80

40.57

3.1

2.6

22.38

22.93

0.47

659

3681

(3044889) 12 lead EKG panel

2703

22587

1.60

40.57

4.2

3.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

804

5021

1.75

40.20

3.0

2.5

12.85

13.13

umol/l

0.52

760

4660

(3004789) Transferrin [Mass/volume] in Serum or Plasma

751

4626

1.77

39.30

2.9

2.5

2.31

2.34

g/l

0.78

707

4280

(3011397) Hemoglobin [Presence] in Urine by Test strip

1108

7576

1.64

39.28

3.7

3.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

813

5126

1.73

39.18

4.4

3.5

0.81

mmol/l

0.55

759

4776

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

246

1007

2.54

38.59

1.8

1.6

316.67

353.48

titre

0.06

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1013

2.52

38.10

2.0

2.4

0.39

1.04

g/l

3.61

221

882

(3018677) aPTT in Platelet poor plasma by Coagulation assay

759

4752

1.74

37.31

2.3

2.2

29.77

29.81

0.07

737

4615

(3037467) Urinalysis macro (dipstick) panel - Urine

2692

22668

1.56

37.27

5.7

4.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

211

824

2.65

36.43

2.0

2.4

0.00

g/l

0.00

196

766

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

1186

2.37

36.29

2.0

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

592

3473

1.83

36.26

4.5

4.1

234.70

247.89

u/l

1.68

567

3276

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

1187

2.37

36.22

2.0

2.3

7.11

7.46

g/l

2.58

214

891

(3048689) Calprotectin [Mass/mass] in Stool

665

4042

1.77

36.16

2.7

2.3

122.88

124.49

ug/g

0.04

550

3178

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

212

833

2.63

36.15

2.0

2.4

0.00

g/l

0.50

197

767

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1184

2.36

35.99

2.0

2.3

3.63

3.79

g/l

1.32

207

848

(3027945) Reticulocytes/100 erythrocytes in Blood

598

3533

1.81

35.75

4.7

2.7

1.75

1.77

0.13

541

3133

(3020630) Protein [Mass/volume] in Serum or Plasma

464

2533

1.94

35.52

2.2

2.6

66.86

66.38

g/l

0.72

427

2309

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1109

2.40

35.50

2.0

2.4

3.00

3.14

g/l

1.61

213

870

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

100

255

4.00

34.92

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

100

255

4.00

34.92

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

100

256

3.98

34.73

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1490

11161

1.53

34.67

3.7

3.3

2.35

2.36

mmol/l

0.41

1358

9747

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

100

258

3.95

34.36

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

100

258

3.95

34.36

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

100

258

3.95

34.36

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

235

4.07

33.72

2.9

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

883

5892

1.64

33.72

3.3

2.9

2.46

2.45

mmol/l

0.29

788

5150

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

224

936

2.48

33.60

2.0

2.2

38.41

37.57

g/l

1.37

202

803

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1106

2.35

33.47

2.0

2.4

10.62

10.27

g/l

0.56

224

938

(3013826) Glucose [Moles/volume] in Serum or Plasma

2302

18960

1.50

33.44

5.6

4.7

6.59

6.66

mmol/l

0.90

2183

17650

(3000494) Fungus identified in Specimen by Culture

615

3741

1.76

33.12

1.7

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

186

4.42

32.48

1.3

1.4

66.15

58.75

titre

0.11

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3404

30669

1.71

32.33

19.6

12.7

82.32

81.33

ml/min/173m2

1.75

2880

25133

(3030981) Hyaline casts [#/volume] in Urine by Automated count

319

1574

2.11

32.26

3.6

2.8

0.27

0.30

e6/l

0.09

313

1521

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1283

9429

1.53

31.99

2.5

2.1

165.40

221.14

u/l

1.54

1207

8833

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3609

33087

1.87

31.98

21.5

13.6

21.60

23.37

mg/l

2.77

3042

26061

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1155

8304

1.55

31.82

2.6

2.3

2.93

2.94

mg/l

0.05

986

7081

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

891

6046

1.61

31.49

4.1

3.6

231.07

414.50

ng/l

2.16

685

4630

(3042936) Bacteria identified in Isolate by Culture

689

4388

1.69

31.27

2.4

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

517

3052

1.80

30.70

2.5

2.1

357.64

372.61

nmol/l

0.97

485

2790

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

582

3562

1.74

30.49

2.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

581

3559

1.74

30.34

2.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

384

2072

1.94

30.24

2.0

2.4

—

(3052851) Hemolysis interference index of Serum or Plasma

222

969

2.37

30.23

3.6

3.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1059

7550

1.55

29.98

1.4

1.3

2.49

1.86

u/ml

0.53

308

1969

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

606

2.71

29.34

7.2

5.5

305.19

616.78

iu/ml

0.60

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

225

1003

2.32

29.19

2.2

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1012

7188

1.54

28.98

1.9

1.8

1.14

1.20

mg/l

0.26

775

5462

(3003458) Phosphate [Moles/volume] in Serum or Plasma

662

4252

1.67

28.89

7.7

6.0

1.06

mmol/l

0.19

626

3952

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

172

682

2.59

28.79

1.4

1.2

3.29

3.31

u/ml

0.00

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

188

786

2.46

28.16

1.7

1.5

15.22

19.60

iu/ml

—

(40768797) Stomach Pathology biopsy report

688

4494

1.64

28.04

1.3

1.2

—

(3002256) Pathology report gross observation

647

4163

1.66

27.97

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

833

5704

1.58

27.90

1.3

34.07

33.32

iu/ml

0.04

253

1780

(3003338) MCHC [Mass/volume]

3158

28219

1.55

27.78

26.8

17.4

331.04

332.00

g/l

7.36

3141

28002

(3022145) Colonoscopy Study observation

570

3564

1.70

27.44

1.4

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

157

4.39

27.12

1.7

1.6

7.51

8.55

ug/l

0.27

136

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

389

2188

1.86

26.89

2.4

28.91

25.04

au/ml

0.21

124

(3022217) INR in Platelet poor plasma by Coagulation assay

614

3939

1.66

26.76

19.4

24.4

1.32

1.33

inr

0.02

562

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

185

3949

0.44

26.52

4.6

4.4

32.70

32.78

0.04

134

2631

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2939

25969

1.49

26.30

4.8

4.1

14.67

14.74

pmol/l

0.82

2773

23648

(46235355) HIV 1 and 2 tests - Meaningful Use set

839

5848

1.55

25.73

1.9

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

998

7221

1.51

25.72

7.1

4.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

575

3664

1.66

25.64

1.8

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

249

3.51

25.07

3.0

2.3

75.17

72.22

1.14

238

(3010375) cycloSPORINE [Mass/volume] in Blood

142

4.42

25.00

32.5

26.9

114.41

120.31

ug/l

0.28

119

(3017181) Myelocytes/100 leukocytes in Blood

453

2737

1.74

24.55

5.9

4.2

0.66

0.89

1.57

128

755

(3025159) Blasts/100 leukocytes in Blood

418

2470

1.77

24.48

6.1

4.3

0.00

0.38

1.27

105

602

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

470

2.76

24.39

4.6

3.2

171.83

1675.63

u/ml

1.09

(3000060) B lymphocytes [#/volume] in Blood

5.26

24.35

3.4

2.7

163.71

142.59

e6/l

0.28

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

181

795

2.34

24.30

2.1

1.9

10.76

11.22

mg/l

0.32

170

727

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

307

1651

1.93

24.30

5.4

4.9

23.97

24.10

mmol/l

0.31

285

1512

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1161

8772

1.45

23.71

3.3

3.0

1584.84

1413.38

ng/l

0.37

1027

7500

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

244

3.45

23.65

3.0

2.3

13.43

12.45

0.29

115

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

170

3.99

23.64

1.6

1.5

7.63

6.15

u/l

0.25

143

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

159

673

2.42

23.20

4.8

3.7

57.23

57.29

0.02

159

673

(3021440) Promyelocytes/100 leukocytes in Blood

431

2608

1.73

23.18

6.0

4.3

0.05

0.18

1.54

119

699

(3014576) Chloride [Moles/volume] in Serum or Plasma

585

3839

1.61

23.03

7.9

7.0

104.50

104.43

mmol/l

0.13

564

3751

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

253

1296

2.02

23.03

2.1

1.8

40.19

38.83

u/l

0.47

233

1146

(3000991) Gas panel - Venous blood

442

2704

1.71

22.84

8.9

8.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

394

2337

1.76

22.72

1.9

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

446

2739

1.71

22.72

6.5

7.3

1.26

1.35

mmol/l

1.55

425

2633

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

775

5449

1.52

22.48

1.3

1.2

14.95

12.06

u/ml

0.44

295

2116

(3026008) Bacteria identified in Urine by Culture

1294

10055

1.42

22.42

3.5

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

388

2340

1.73

21.06

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

343

2000

1.78

20.94

1.3

46.56

51.56

au/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

482

3094

1.63

20.63

2.5

2.3

0.22

0.21

g/l

1.58

448

2895

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

9.65

20.55

1.6

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3326

30586

1.50

20.45

5.8

4.8

1.90

2.14

mu/l

1.45

3161

28096

(3002032) Base excess in Venous blood by calculation

467

2998

1.63

19.95

5.3

4.3

1.54

1.91

mmol/l

1.47

391

2433

(3011412) CD3 cells [#/volume] in Blood

312

2.93

19.56

3.0

2.3

1.25

1.19

e9/l

0.22

188

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1459

11786

1.37

19.37

4.2

3.5

42.51

91.03

ng/l

0.62

947

7792

(3021447) Carbon dioxide [Partial pressure] in Venous blood

465

3003

1.62

19.37

5.3

4.2

5.76

5.84

kpa

0.96

453

2920

(3013727) Leukocytes other/100 leukocytes in Blood

108

4.39

18.93

8.2

4.5

55.03

51.92

0.38

102

(21491868) Cryoglobulin [Mass/volume] in Serum

109

4.35

18.71

1.2

1.3

—

0.25

g/l

—

(3032080) INR in Blood by Coagulation assay

1537

12578

1.36

18.58

10.9

9.0

1.19

1.24

inr

1.82

466

3688

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

150

684

2.24

18.49

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

150

684

2.24

18.49

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

398

2503

1.65

18.40

5.0

4.0

0.45

0.60

0.87

553

(3023103) Potassium [Moles/volume] in Serum or Plasma

3597

33828

1.59

18.01

22.5

15.7

3.95

3.96

mmol/l

1.40

3547

32887

(3019550) Sodium [Moles/volume] in Serum or Plasma

3588

33727

1.58

17.96

22.3

15.6

139.46

139.66

mmol/l

5.23

3540

32850

(3051611) Lipemic interference index of Serum or Plasma

337

2.74

17.54

3.4

3.5

—

(40761511) CBC panel - Blood by Automated count

3648

34458

1.62

17.50

17.1

12.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

830

6187

1.43

17.37

1.7

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

396

2524

1.63

17.33

4.5

4.0

95.92

88.25

ng/l

0.74

357

2160

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

711

5153

1.46

17.29

2.1

1.8

—

(3036489) Thrombin time

221

1195

1.90

17.18

2.4

21.17

21.56

0.43

199

1049

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

189

970

2.00

17.13

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

177

888

2.04

17.09

7.1

5.2

1.57

1.51

mg/l

0.34

164

814

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3683

34906

1.64

16.98

23.6

15.7

77.41

75.21

umol/l

2.53

3683

34892

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

244

3.03

16.97

1.2

246.00

174.62

titre

0.26

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

253

1435

1.81

16.91

1.1

0.93

1.35

u/ml

—

(4035726)

438

2881

1.58

16.81

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

959

7376

1.39

16.68

1.7

1.5

20.80

20.77

nmol/l

0.02

862

6270

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

179

915

2.00

16.42

3.2

2.9

185.46

189.84

0.29

170

878

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

180

927

1.99

16.17

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

135

624

2.20

16.14

1.6

1.7

—

(3051651) Icteric interference index of Serum or Plasma

194

3.23

16.11

3.2

3.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

180

929

1.98

16.07

1.3

1.4

267.93

286.21

ug/g

0.56

106

523

(3014765) Yersinia sp identified in Stool by Organism specific culture

181

937

1.98

16.02

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

192

1015

1.94

15.99

2.5

2.7

93.14

91.80

0.37

181

951

(3024354) Oxygen [Partial pressure] in Venous blood

385

2490

1.60

15.84

4.6

3.7

4.93

4.64

kpa

1.44

374

2414

(42529406) Shigella sp [Presence] in Stool by Culture

180

944

1.95

15.35

1.2

—

(3021901) Oxygen saturation in Capillary blood

125

573

2.22

15.27

3.6

3.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

422

2824

1.55

14.96

10.1

7.7

9.71

9.70

mmol/l

0.01

409

2693

(3006184) Hemoglobin [Mass/volume] in Capillary blood

145

712

2.08

14.87

2.4

2.3

131.62

128.06

g/l

0.94

115

520

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

220

2.99

14.83

3.0

2.4

775.00

685.12

e6/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

3264

30389

1.39

14.49

22.7

14.7

39.64

39.51

0.52

2629

22116

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1233

10042

1.33

14.45

2.9

2.5

59.06

57.95

u/l

0.18

1145

9244

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

102

441

2.35

14.31

1.8

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

114

517

2.24

14.31

1.8

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

165

861

1.96

14.30

6.1

4.7

8.60

8.53

kpa

0.21

158

805

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

109

486

2.28

14.25

1.3

1.97

3.83

u/ml

1.55

172

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

238

1396

1.75

14.21

1.7

1.8

1.58

1.54

g/l

0.21

203

1213

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2409

21509

1.30

14.07

3.4

3.0

—

(1616796) Gas panel - Central venous blood

142

710

2.04

13.89

4.4

3.8

—

(3044640) Blood type and Crossmatch panel - Blood

1267

10408

1.32

13.85

2.9

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

180

979

1.88

13.78

1.4

1.6

0.20

7.07

iu/ml

0.58

198

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

667

4966

1.41

13.73

1.7

1.6

—

(4062490)

322

2.55

13.65

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

266

1628

1.68

13.61

1.2

1.1

233.33

154.36

titre

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

107

483

2.25

13.60

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

226

2.86

13.56

1.2

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

300

1898

1.63

13.48

1.8

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

167

894

1.91

13.43

1.3

1.2

336.67

1011.03

titre

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

320

2.53

13.32

1.4

2.85

2.87

g/l

0.02

231

(3024139) IgG subclass 3 [Mass/volume] in Serum

320

2.53

13.32

1.4

0.39

0.40

g/l

0.08

231

(3027135) IgG subclass 1 [Mass/volume] in Serum

320

2.53

13.32

1.4

6.66

6.87

g/l

0.21

230

(3024980) IgG subclass 4 [Mass/volume] in Serum

111

514

2.19

13.27

1.6

1.5

0.52

0.74

g/l

2.34

395

(3051387) C reactive protein [Mass/volume] in Capillary blood

143

729

2.00

13.27

5.4

3.6

25.36

25.70

mg/l

0.03

104

456

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

189

1058

1.83

13.22

2.2

2.3

222.70

689.36

ug/l

1.62

169

981

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

131

650

2.05

13.10

1.6

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.87

13.05

1.5

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

366

2.41

13.01

16.7

5.7

7.37

7.19

mmol/l

0.22

306

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

130

648

2.04

12.85

1.6

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

148

3.27

12.84

7.9

4.0

—

(3029937) Albumin [Presence] in Urine by Test strip

1060

8569

1.32

12.79

5.2

4.0

0.00

estimate

1.70

410

2972

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

172

945

1.86

12.78

2.3

3.3

1.49

1.66

ratio

0.27

(3007566) Smooth muscle Ab [Titer] in Serum

164

891

1.88

12.63

1.3

1.2

98.89

92.39

titre

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

289

1842

1.61

12.60

1.4

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

174

965

1.84

12.56

2.9

3.43

3.56

g/l

0.57

165

913

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3667

35046

1.51

12.53

14.8

10.1

25.74

25.41

u/l

0.51

3600

33797

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

326

2143

1.57

12.47

2.9

3.2

4.43

4.47

pmol/l

0.30

292

1907

(3003327) Ova and parasites identified in Stool by Light microscopy

188

1072

1.79

12.39

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

221

2.79

12.36

3.2

2.4

593.25

513.94

e6/l

0.44

185

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

174

971

1.83

12.31

2.3

3.3

38.35

52.10

mg/l

0.71

143

791

(3034860) Kappa light chains.free [Mass/volume] in Serum

174

972

1.83

12.27

2.4

3.3

56.35

58.36

mg/l

0.06

143

792

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

164

902

1.85

12.16

1.9

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

213

2.80

12.05

1.9

1.6

—

(3019225) pH of Specimen

196

3235

0.59

12.01

4.6

4.3

—

(3029075) Extractable nuclear Ab panel - Serum

3.74

11.81

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1444

12271

1.28

11.68

4.8

3.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

103

3.62

11.59

2.3

2.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

147

794

1.88

11.55

4.6

4.1

24.35

24.94

mmol/l

0.94

140

699

(3000475) Leukocytes [#/volume] in Synovial fluid

138

730

1.92

11.55

1.8

1.7

12591.95

13188.62

e6/l

0.07

102

515

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

128

3.31

11.47

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

467

2.15

11.35

1.3

2.86

4.84

u/ml

1.67

214

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

533

2.05

11.02

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1058

8699

1.29

10.98

4.5

3.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

177

1029

1.75

10.95

3.4

3.3

0.31

0.35

u/ml

0.66

107

597

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1038

8524

1.29

10.85

1.7

1.6

1.37

1.36

mmol/l

0.10

910

7197

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

3.13

10.55

1.3

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

117

605

1.96

10.50

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

282

1866

1.55

10.49

1.4

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

141

776

1.85

10.48

2.3

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

115

592

1.97

10.46

1.7

1.4

121.37

114.93

u/ml

0.11

107

(3024891) Influenza virus A+B Ag [Presence] in Specimen

157

895

1.78

10.40

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

111

3.35

10.39

2.8

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

298

2.37

10.28

1.3

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

745

5887

1.33

10.26

1.8

1200.22

1167.29

nmol/l

0.45

578

4436

(36660697) Celiac disease serology panel - Serum

388

2759

1.45

10.16

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

369

2599

1.46

10.16

2.8

2.7

73.59

69.82

e9/l

0.96

235

1950

(3026250) Tacrolimus [Mass/volume] in Blood

133

3.10

10.16

27.2

34.8

6.69

7.33

ug/l

0.93

123

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

370

2.21

10.10

2.0

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

213

2.60

9.87

3.4

2.4

0.24

0.21

e9/l

0.57

185

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

3.24

9.84

1.0

1.3

0.31

0.30

g/l

0.32

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

109

564

1.96

9.79

1.9

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

333

2.25

9.59

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

232

1502

1.58

9.51

2.1

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

1164

9830

1.26

9.46

3.8

3.2

7.31

7.36

mmol/l

0.13

1013

8273

(3048929) Epstein Barr virus Ab [Presence] in Serum

169

1012

1.70

9.45

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

117

629

1.89

9.39

1.3

286.29

267.15

u/ml

0.17

366

(3044941) Cell count panel - Synovial fluid

496

2.00

9.39

1.7

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

246

1620

1.55

9.36

8.8

9.7

24.02

24.28

mmol/l

0.66

230

1520

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2362

21565

1.23

9.18

3.5

3.0

46.16

45.99

u/l

0.03

2245

20076

(3003396) Base excess in Arterial blood by calculation

473

3545

1.38

9.17

7.3

7.5

0.80

1.09

mmol/l

0.84

389

2764

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

358

2557

1.44

9.15

2.8

2.7

65.13

66.37

ml/min/173m2

0.23

154

1019

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

395

2.10

8.99

6.9

6.8

12.23

11.92

mg/l

0.23

368

(40760888) Immunoglobulin light chains.free panel - Serum

127

712

1.81

8.95

2.2

3.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

397

2.09

8.88

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

489

3703

1.36

8.88

1.8

1.7

1.42

1.43

0.21

434

3250

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

214

2.50

8.78

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

252

1696

1.52

8.70

1.3

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

174

2.66

8.69

3.3

2.6

35.76

40.93

0.59

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

120

3.02

8.57

2.5

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

425

2.02

8.46

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

154

930

1.68

8.38

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

441

3315

1.37

8.38

4.3

3.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

311

2204

1.45

8.30

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

135

790

1.73

8.25

1.5

1.4

—

(3000492) Spirometry study

411

3063

1.38

8.23

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3321

31621

1.28

8.22

4.8

4.4

5.87

5.89

mmol/l

0.39

3129

28836

(3021788) Differential panel - Synovial fluid

102

549

1.88

8.21

1.8

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

174

2.60

8.16

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

466

3548

1.35

8.16

7.4

7.5

12.31

12.49

kpa

0.30

446

3384

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

466

3548

1.35

8.16

7.4

7.5

5.02

5.10

kpa

1.33

447

3381

(3004809) Band form neutrophils/100 leukocytes in Blood

508

1.91

8.14

5.1

3.5

1.57

1.39

0.17

398

(3045142) Bone marrow Pathology biopsy report

364

2.08

8.10

1.6

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

432

1.99

8.10

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3136

29679

1.25

8.01

6.3

5.5

39.61

39.57

mmol/mol

0.08

2991

27443

(3007461) Platelets [#/volume] in Blood

3787

36801

1.48

8.00

30.5

20.2

255.67

255.09

e9/l

0.21

3723

35816

(3009214) Lutropin [Units/volume] in Serum or Plasma

144

868

1.68

7.91

1.4

10.58

11.22

u/l

0.22

112

696

(21494814) CD8 cells/100 lymphocytes in Specimen

126

2.87

7.89

2.3

2.1

—

(3026361) Erythrocytes [#/volume] in Blood

3788

36825

1.47

7.85

30.4

20.1

4.43

4.47

e12/l

4.49

3717

35744

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

119

683

1.76

7.80

2.0

1.6

464.50

1243.98

e6/l

0.78

548

(3024731) MCV [Entitic volume]

3787

36819

1.47

7.78

30.4

20.1

91.05

90.87

1.53

3761

36284

(3035941) MCH [Entitic mass]

3787

36819

1.47

7.78

30.3

20.1

30.23

0.00

3762

36281

(3010813) Leukocytes [#/volume] in Blood

3788

36831

1.47

7.78

30.5

20.2

6.85

6.71

e9/l

1.66

3720

35738

(3000963) Hemoglobin [Mass/volume] in Blood

3788

36835

1.47

7.73

30.6

20.3

132.83

134.23

g/l

8.03

3762

36301

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.33

7.67

1.2

0.02

0.04

u/ml

0.34

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

116

666

1.76

7.60

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

118

682

1.75

7.56

2.0

1.5

11.82

29.95

e6/l

0.94

516

(3024263) Appearance of Synovial fluid

164

2.58

7.50

2.0

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

459

1.92

7.47

1.3

0.60

0.63

nmol/l

0.22

442

(44790049)

363

2.03

7.43

1.8

1.5

—

(44806118)

363

2.03

7.43

1.8

1.5

—

(44790048)

363

2.03

7.43

1.8

1.5

—

(44790047)

363

2.03

7.43

1.8

1.5

—

(3023410) Appearance of Cerebral spinal fluid

317

2.10

7.36

2.5

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

208

1394

1.52

7.36

3.4

3.1

0.67

0.66

0.17

201

1345

(3000330) Specific gravity of Urine by Test strip

235

1616

1.48

7.35

3.5

3.4

—

(4268621)

333

2.06

7.22

2.3

2.4

—

(3036603) Volume of Urine

210

2.35

7.20

1.6

1.4

2174.70

1924.95

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.94

7.15

5.8

7.3

—

(1002224) Polysomnography panel

191

1267

1.53

7.10

1.1

—

(3019150) Specific gravity of Urine by Refractometry

827

6917

1.25

7.01

4.8

4.1

1.01

1.02

kg/l

0.85

1045

(3013293) Extractable nuclear Ab [Presence] in Serum

3.86

6.97

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

102

2.96

6.95

2.7

2.0

9.44

9.88

mg/l

0.14

(3023323) Follitropin [Units/volume] in Serum or Plasma

236

1643

1.46

6.95

1.4

32.40

29.18

iu/l

0.67

204

1397

(40767503) Oxygen content in Capillary blood by calculation

115

677

1.72

6.94

3.4

2.6

17.24

16.13

2.24

341

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

340

2.02

6.84

1.3

1.2

75.24

55.31

u/l

0.90

230

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

293

2.10

6.83

3.6

3.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

646

1.72

6.71

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.94

6.68

1.6

9.29

8.33

ug/l

0.59

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

544

1.78

6.63

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

147

936

1.59

6.56

1.5

1.3

—

(3012501) Base excess in Blood by calculation

121

734

1.67

6.56

5.2

4.4

2.53

2.69

mmol/l

0.28

492

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

184

1237

1.51

6.46

2.3

1.9

1.94

2.08

ug/l

0.07

167

1091

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.07

6.46

1.0

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

354

2681

1.35

6.41

5.4

3.7

1.23

mmol/l

0.09

322

2341

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

126

778

1.64

6.39

1.8

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

124

763

1.65

6.37

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

405

3133

1.33

6.36

8.1

8.0

95.60

95.67

0.08

394

3020

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1705

15411

1.18

6.33

4.7

4.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.68

6.31

5.2

5.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.68

6.31

5.0

5.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

319

2387

1.37

6.25

1.2

115.15

152.48

iu/ml

1.20

124

907

(3044242) Glucose [Moles/volume] in Arterial blood

162

2.42

6.18

2.4

2.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.80

6.10

1.1

—

(40761536) Microorganisms panel - Urine sediment

367

2818

1.33

6.07

5.5

4.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

377

2907

1.33

6.06

8.2

8.4

119.31

120.90

g/l

0.80

367

2796

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

2.37

6.04

3.0

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

2.37

6.04

3.0

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

429

1.83

5.97

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.85

5.93

2.1

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.85

5.93

2.1

2.9

—

(3028707) Methadone [Presence] in Urine by Screen method

504

1.76

5.90

3.7

2.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

113

2.67

5.82

1.3

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

124

782

1.60

5.81

1.7

1.4

430.52

532.73

mg/l

3.54

117

741

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

285

2.01

5.79

1.9

1.4

28.96

32.12

0.30

174

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.39

5.76

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

161

1082

1.51

5.70

2.6

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

246

1793

1.40

5.68

2.2

11.82

11.89

nmol/l

0.05

210

1571

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

149

986

1.53

5.67

2.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1092

9566

1.19

5.67

4.3

4.0

12.67

11.04

mg/mmol

0.26

718

5988

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

481

1.76

5.66

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

134

867

1.56

5.64

1.9

1.8

—

(4306422)

475

1.76

5.60

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

2.32

5.50

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

111

691

1.62

5.50

1.7

1.4

3.65

3.74

mmol/l

0.38

105

648

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.81

5.49

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

231

1676

1.40

5.48

2.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

100

2.71

5.42

1.6

1.3

56.76

54.11

0.12

(3012516) Albumin [Mass/volume] in Urine

1036

9066

1.19

5.40

3.4

3.2

345.76

312.16

mg/l

0.09

668

5649

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.87

5.34

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

294

1.95

5.34

3.4

3.1

57.71

30.24

mg/l

0.56

214

(3010421) pH of Blood

132

863

1.55

5.33

5.3

4.1

7.42

0.03

118

726

(3009871) Measles virus Ab [Titer] in Serum

101

2.68

5.33

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

105

651

1.63

5.30

2.0

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

117

745

1.59

5.30

2.3

1.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.29

5.30

1.5

1.8

0.37

0.21

nmol/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.34

5.29

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

244

1799

1.38

5.28

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

338

1.88

5.26

2.0

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

898

1.53

5.26

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

156

2.32

5.25

2.9

3.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

177

1235

1.45

5.23

1.7

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

531

1.69

5.21

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

347

1.86

5.18

1.1

1.2

91.64

96.31

0.80

328

(4010399)

296

2257

1.34

5.16

1.5

1.4

—

(3019977) pH of Arterial blood

170

2.25

5.16

2.6

3.1

7.42

7.43

0.07

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3393

32765

1.22

5.14

5.3

4.7

2.71

2.78

mmol/l

4.56

3217

30181

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.20

5.09

1.8

1.7

0.12

1.31

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.20

5.09

1.8

1.7

0.96

1.89

mg/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

415

1.77

5.08

3.0

2.5

5.89

8.71

umol/l

0.84

300

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.45

5.03

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

287

1.93

5.01

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.64

4.97

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

335

2614

1.31

4.97

2.5

3.0

227.72

196.62

ng/l

0.54

302

2365

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

161

2.25

4.90

1.2

1.1

29.67

11.78

u/ml

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.07

4.89

1.8

1.7

0.91

1.37

mg/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

305

1.88

4.83

1.4

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.59

4.78

2.2

3.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

357

1.81

4.76

3.0

3.4

3.25

20.77

nmol/l

0.59

346

(3021387) Prolactin [Units/volume] in Serum or Plasma

165

1158

1.44

4.76

2.0

1.6

345.39

306.05

mu/l

0.64

147

1048

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

846

1.52

4.75

1.9

4.88

4.45

iu/l

0.13

316

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.28

4.74

2.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

380

1.78

4.72

1.3

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.95

4.71

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

700

5980

1.21

4.69

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

532

1.65

4.68

1.2

—

(3023419) Bacteria identified in Sputum by Culture

397

1.75

4.64

2.8

2.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

403

3251

1.27

4.62

2.3

1.9

—

(3003181) Sodium [Moles/volume] in Urine

565

1.62

4.62

1.4

58.84

64.94

mmol/l

0.86

457

(3011288) Drugs identified in Urine by Screen method

120

795

1.53

4.61

4.7

3.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.22

4.61

1.2

2.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

466

1.69

4.59

1.2

121.35

117.19

0.58

422

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

161

1138

1.43

4.49

3.2

3.3

2131.05

3906.84

u/ml

0.27

133

944

(3024932) HLA-DR beta [Type]

2.53

4.45

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

2.53

4.45

4.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

414

3367

1.26

4.43

3.5

4.0

9.66

20.44

ug/l

1.23

338

2695

(21494434) Karyotype in Bone marrow

286

1.86

4.41

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

100

645

1.56

4.35

2.8

3.0

43.03

34.86

umol/l

0.43

546

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.24

4.35

4.8

4.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

445

3659

1.24

4.33

2.4

2.0

—

(3008898) HLA-B27 [Presence]

162

1155

1.42

4.32

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

131

903

1.47

4.19

3.3

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

382

3099

1.26

4.19

1.7

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

121

2.32

4.17

1.0

1.1

—

(3024471) HLA-A [Type]

103

2.44

4.13

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

320

2546

1.28

4.13

2.2

2.3

6.82

6.84

ug/l

0.01

287

2209

(44816559) Phosphatidylethanol [Mass/volume] in Blood

560

1.58

4.08

1.2

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

244

1876

1.32

4.07

4.0

3.5

129.28

128.24

g/l

0.35

239

1829

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.63

4.06

1.3

1.1

—

(3027008) Opiates [Presence] in Urine

161

1161

1.40

4.05

3.0

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

182

2.04

4.03

1.3

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

407

1.68

4.02

1.3

—

nmol/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

281

1.83

4.01

1.5

1.4

105219.68

97400.95

e6/l

0.04

187

(3022621) pH of Urine by Test strip

273

2138

1.30

3.99

2.9

—

(3001729) Color of Synovial fluid

3.94

3.97

1.7

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

105

2.39

3.97

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

253

1.87

3.97

1.2

1.4

13.33

12.65

mmol/l

0.17

(3028300) Cannabinoids [Presence] in Urine

161

1166

1.40

3.95

3.0

2.2

—

(3024928) Oxygen saturation in Venous blood

101

669

1.52

3.94

3.2

3.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3321

32181

1.18

3.92

4.8

4.2

4.60

4.71

mmol/l

8.05

3156

29835

(4027681)

171

2.06

3.90

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

158

1144

1.40

3.89

2.8

2.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.51

3.87

1.1

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

169

1239

1.38

3.87

2.4

2.2

4489.37

6165.94

u/l

0.37

494

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

152

2.11

3.83

11.8

5.8

88.50

53.34

u/ml

0.34

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

546

1.57

3.81

1.8

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.43

3.80

1.7

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

158

1152

1.39

3.75

3.0

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

318

3916

0.80

3.72

9.0

6.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

3.69

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

4.01

3.69

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

2.20

3.69

1.0

1.1

1557.29

1492.09

miu/ml

0.13

128

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

231

1.87

3.68

1.2

1.1

43.22

40.18

mg/l

0.12

197

(46236302) HLA-C [Type] by High resolution typing

6.68

3.67

1.0

—

(40760409) HLA-A [Type] by High resolution

6.68

3.67

1.0

—

(40760410) HLA-B [Type] by High resolution

6.68

3.67

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3182

30771

1.16

3.66

4.2

3.8

1.30

1.28

mmol/l

1.07

2984

28167

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.63

3.65

4.3

2.9

2.74

3.46

mg/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

239

1.85

3.64

1.7

1.2

0.55

0.83

u/ml

0.23

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1326

0.66

3.63

2.0

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.35

3.57

1.2

1.3

105.10

88.26

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

164

2.02

3.54

1.6

2.1

11.33

183.63

ug/min

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

178

1.97

3.52

1.3

1.2

—

(3034426) Prothrombin time (PT)

112

2.24

3.47

1.1

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.62

3.46

1.1

—

(3016038) Potassium [Moles/volume] in Urine

209

1.87

3.39

1.6

1.3

34.95

34.33

mmol/l

0.06

181

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

475

1.57

3.37

1.6

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

305

1.71

3.37

1.4

2.0

—

(3016879) Cocaine [Presence] in Urine

145

1063

1.38

3.36

3.1

2.2

—

(3004451) EKG impression Narrative

154

2.02

3.34

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1.88

3.34

2.0

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3289

31943

1.16

3.33

4.6

4.2

1.47

1.49

mmol/l

3.52

3105

29438

(3014007) Fractional oxyhemoglobin in Arterial blood

243

1923

1.28

3.32

10.6

9.3

94.06

93.93

0.10

243

1915

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

225

1.83

3.32

1.1

1.0

228.32

272.39

mg/l

1.16

202

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

269

1.76

3.32

1.5

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.62

3.30

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

464

1.56

3.24

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

257

1.76

3.21

1.9

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

635

1.48

3.21

1.8

2.1

0.84

0.79

nmol/l

0.32

530

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

410

1.59

3.20

1.7

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

164

1.96

3.18

1.0

1.01

1.14

u/l

0.64

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.73

3.15

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.23

3.05

1.2

1.1

95.20

89.68

—

(3010937) Rubella virus Ab [Presence] in Serum

5.01

3.05

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

217

1.81

3.05

1.6

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.45

3.04

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1206

0.68

3.03

1.9

1.8

—

(40763590) HLA-DQ beta [Type]

5.84

3.02

1.0

—

(3013862) HLA-DP [Type]

5.84

3.02

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

403

1.57

2.96

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

427

1.55

2.95

1.9

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

179

0.28

2.95

2.0

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

250

1.73

2.91

2.9

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

877

7912

1.14

2.88

2.8

2.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

115

2.09

2.88

1.0

1.1

2.99

2.72

u/ml

0.05

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.51

2.87

1.1

0.68

0.67

umol/24h

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.67

2.86

6.7

9.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

352

1.60

2.84

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

291

1.66

2.81

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

117

2.06

2.76

4.0

3.8

8.20

7.91

mg/l

0.09

(3042631) Mycobacterium sp identified in Specimen

404

1.54

2.71

3.2

2.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

617

1.44

2.70

4.7

3.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

510

1.48

2.69

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.22

2.67

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

694

1.41

2.67

1.2

1.1

1.74

1.89

u/ml

0.07

296

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.76

2.67

1.4

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

771

1.38

2.65

3.8

4.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

265

2182

1.23

2.63

2.2

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.67

2.59

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

214

1.74

2.59

1.1

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

247

2023

1.24

2.58

5.6

4.3

1.67

1.77

mmol/l

0.17

182

1490

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.61

2.57

1.3

1.2

13.33

23.04

u/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

212

1711

1.25

2.53

2.0

1.7

—

(4146454)

342

0.47

2.51

2.8

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1.79

2.51

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

372

1.54

2.50

2.7

1.7

6016.00

1160.00

titre

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

309

1.59

2.49

2.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

233

2833

0.81

2.49

1.7

—

(3025130) Human papilloma virus identified in Specimen

478

1.47

2.49

1.6

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

217

1.71

2.48

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

294

1.61

2.47

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

180

1.78

2.47

2.1

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

226

1.69

2.43

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

343

1.55

2.42

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

473

1.47

2.42

1.7

1.4

—

(3009343) pH of Capillary blood

252

2085

1.22

2.41

5.7

4.4

7.42

7.41

0.86

250

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

212

1.70

2.39

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

329

1.56

2.37

4.1

4.7

139.51

78.68

u/ml

0.24

(3014891) Appearance of Pleural fluid

2.75

2.37

1.9

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

254

2109

1.22

2.35

5.7

4.4

5.00

5.17

kpa

2.72

243

1965

(3015076) Soybean IgE Ab [Units/volume] in Serum

191

1.73

2.33

1.1

0.17

2.86

u/ml

—

(3017569) Oxygen content in Arterial blood

147

1.84

2.32

2.4

2.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

364

1.52

2.29

2.3

2.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

192

1.72

2.29

1.1

4.18

5.03

nmol/l

0.09

(3023511) Choriogonadotropin [Units/volume] in Urine

655

1.38

2.29

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

215

1.68

2.28

1.7

1.5

3.19

6.57

u/l

1.56

104

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

504

4449

1.15

2.28

2.9

3.0

0.72

0.76

ug/l

0.41

366

2930

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

148

1.83

2.28

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

521

1.43

2.27

1.2

1.1

48.08

1069.59

iu/ml

0.53

127

(40768795) Lymph node Pathology biopsy report

301

1.57

2.27

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

357

1.52

2.27

6.7

3.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

254

1.62

2.26

1.3

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

133

1030

1.30

2.25

1.3

241.35

227.30

miu/ml

0.15

510

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

498

1.43

2.23

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

432

1.47

2.23

2.4

1.8

90.25

89.62

0.51

426

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

248

1.62

2.21

1.1

11.56

8.91

iu/ml

0.18

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

180

1.73

2.18

2.2

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

1.84

2.17

4.4

4.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

211

1.66

2.16

1.0

—

(3047189) Immunofixation for 24 hour Urine

144

1.81

2.14

1.7

1.6

—

(3011648) Oxygen content in Venous blood

266

1.59

2.14

2.6

4.6

10.72

11.01

0.16

266

(4034850)

1092

0.73

2.14

7.4

9.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.14

2.08

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.26

2.07

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.00

2.07

1.4

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

5.00

2.07

1.0

1.6

1.22

1.34

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

498

1.41

2.06

1.3

1.2

—

(3013512) EKG study

841

9145

0.90

2.06

4.4

3.8

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.00

2.04

1.2

3.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.40

2.02

1.3

1.4

13.57

648787.57

nmol/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

216

1.63

2.00

1.3

1.1

6.89

3.12

u/ml

0.25

(3027273) Bicarbonate [Moles/volume] in Venous blood

179

1462

1.23

1.99

4.6

3.2

25.20

25.32

mmol/l

0.21

174

1417

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

201

1.65

1.98

1.7

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.15

1.98

1.1

0.08

12.69

u/ml

0.94

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

320

1.51

1.98

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

562

1.38

1.97

1.1

1.55

2.46

u/ml

0.69

146

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

1.85

1.96

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.36

1.94

1.7

1.5

—

(3011985) Renin [Units/volume] in Plasma

412

1.44

1.94

1.7

1.5

46.85

42.88

mu/l

0.12

365

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.19

1.94

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.19

1.94

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.19

1.94

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.19

1.94

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

230

1938

1.20

1.88

7.9

7.1

24.81

24.56

mmol/l

0.57

221

1809

(3037692) Legionella sp identified in Specimen by Organism specific culture

100

1.90

1.85

1.7

1.3

—

(21494755) Public health laboratory ask at order entry panel

259

3017

0.85

1.81

1.4

1.3

—

(40768441) Liver Pathology biopsy report

254

1.54

1.81

1.6

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.27

1.80

1.5

—

(3028433) Virus identified in Specimen by Culture

101

1.89

1.80

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

116

1.81

1.78

1.1

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.17

1.77

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

471

1.39

1.77

1.1

5.10

3.41

u/ml

0.35

222

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

713

1.31

1.76

2.6

2.4

142.26

98.36

ug/min

0.43

442

(4198724)

124

1.78

1.75

1.9

3.4

—

(3008295) Osmolality of Serum or Plasma

346

1.45

1.75

1.4

1.5

281.65

279.07

mosm/kgh2o

0.32

263

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.50

1.74

1.0

1.2

1.76

1.84

umol/24h

—

(4094501)

109

856

1.28

1.73

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

744

6852

1.11

1.69

1.8

1.7

35202924.57

28318860.84

pmol/l

0.12

642

5703

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.16

1.66

4.2

2.5

—

(3042517) Benzodiazepines panel - Urine

2.80

1.65

3.9

1.8

—

(3003694) ABO and Rh group [Type] in Blood

978

9138

1.09

1.64

1.6

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

829

7688

1.10

1.64

4.7

4.9

2.43

3.63

ug/l

1.25

757

6836

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

205

1.57

1.62

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

151

1.66

1.59

1.9

1.7

1.80

4.68

nmol/l

1.10

122

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.59

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

223

1.53

1.56

1.2

1.1

5.93

1.85

u/ml

0.37

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.85

1.55

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

156

1296

1.21

1.54

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

323

1.43

1.53

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.34

1.52

2.0

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

138

1.67

1.51

1.9

2.6

91.80

169.64

umol/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

146

1.65

1.50

1.5

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1096

0.78

1.50

1.4

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

620

1.30

1.45

1.1

7.20

4.62

u/ml

0.56

334

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.92

1.43

1.1

1.3

—

(40768446) Kidney Pathology biopsy report

125

1.68

1.43

1.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1210

0.80

1.43

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

172

1.57

1.42

1.2

1.1

14.21

22.45

u/l

1.00

128

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

172

1.57

1.42

1.2

1.1

59.97

78.35

u/l

1.47

132

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

693

0.73

1.42

1.8

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

491

1.33

1.42

1.5

1.4

26.75

28.67

u/l

0.20

407

(3045424) Erythrocytes [Presence] in Urine

561

1.31

1.41

1.8

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.25

1.40

3.3

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

197

1.53

1.40

1.2

1.1

1.07

1.04

ratio

0.82

(3008401) Mugwort IgE Ab [Units/volume] in Serum

598

1.29

1.39

1.1

0.71

1.29

u/ml

0.65

277

(3036071) Salmonella sp Ab [Titer] in Serum

119

1.68

1.37

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

1217

11565

1.07

1.33

3.1

2.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.10

1.30

2.3

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

386

1.35

1.29

1.3

321.92

283.82

pmol/l

0.31

300

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

145

1.59

1.28

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

169

1.54

1.28

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

344

1.37

1.28

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.94

1.27

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

780

1.24

1.22

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

373

1.34

1.22

1.8

1.6

61.15

59.31

0.14

232

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

163

1898

0.85

1.21

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

221

1938

1.15

1.20

3.2

3.4

60.96

54.18

u/ml

0.13

210

1875

(3035880) pH of Pleural fluid

164

1.53

1.20

1.2

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

523

1.29

1.20

1.5

1.4

0.45

0.37

nmol/l

0.21

410

(3050794) Legionella sp Ab [Presence] in Serum

2.31

1.18

1.2

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

437

1.31

1.17

1.1

6.23

5.14

u/ml

0.19

185

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.15

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.50

1.15

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.81

1.15

1.1

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

134

1.57

1.14

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.34

1.12

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.3

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.38

1.09

2.8

1.5

384.40

333.76

umol/24h

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.73

1.08

1.1

1.4

146.88

123.60

nmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

355

1.33

1.08

1.1

1.2

—

(40761535) Cells panel - Urine sediment

288

2590

1.12

1.08

3.6

3.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.87

1.07

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

109

914

1.20

1.06

5.5

4.0

3.95

3.86

mmol/l

0.98

855

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

117

1379

0.84

1.04

7.5

4.5

24.18

24.75

mmol/l

1.79

111

1283

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

237

1.40

1.04

1.7

—

(3019174) dRVVT (LA screen)

2.06

1.02

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.06

1.02

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.92

1.02

1.1

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.65

1.00

1.2

38.94

40.15

g/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

147

1.50

1.00

2.3

55.38

53.60

umol/l

0.10

120

(44813793)

239

1.38

1.00

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

369

1.30

1.00

3.8

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

158

0.57

0.98

1.2

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.18

0.98

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

116

1.55

0.96

1.2

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1021

0.83

0.95

1.7

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

0.94

1.1

1.8

45.29

39.81

umol/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.89

0.94

1.4

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

117

1.54

0.93

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.22

0.93

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

234

1.37

0.93

1.3

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

146

0.55

0.92

3.3

14.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

396

0.73

0.92

3.2

2.2

19.25

22.99

mg/l

—

106

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.14

0.91

1.3

1.0

—

(3044927) Protein electrophoresis panel - Urine

302

0.69

0.90

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

1.6

6.17

16.22

pmol/l

—

(3000012) Reticulocyte production index

160

1.44

0.88

1.7

1.5

—

(3016750) Collection duration of Urine

177

1.42

0.88

2.6

2.3

506.67

492.29

min

0.22

137

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.86

0.87

1.4

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.87

1.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

168

0.59

0.86

1.5

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

168

0.59

0.86

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

168

0.59

0.86

1.5

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

168

0.59

0.86

1.5

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.82

0.85

1.1

1.3

—

(3037121) Protein [Mass/volume] in Urine

126

1095

1.16

0.84

5.2

3.6

0.20

0.30

g/l

1.36

453

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.78

0.84

6.5

12.9

4.34

5.77

mmol/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

137

0.58

0.83

1.5

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.74

0.82

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.69

0.82

1.7

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

163

1.41

0.82

3.0

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.88

0.81

1.3

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

198

1.37

0.80

24.5

17.1

1314.22

1521.23

nmol/l

0.82

193

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.82

0.79

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

268

1.31

0.79

1.9

2.2

1.59

2.07

u/field

0.35

110

(3034891) Synovial lining cells/100 cells in Synovial fluid

148

1.42

0.77

1.8

1.3

12.00

2.70

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

2.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

107

1.50

0.76

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

187

1683

1.12

0.76

10.4

10.6

—

(4281824)

377

1.25

0.75

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

185

0.65

0.75

1.5

1.3

—

(40768793) Breast Pathology biopsy report

102

884

1.16

0.74

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

0.59

0.72

1.5

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

0.59

0.72

1.5

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

525

1.20

0.72

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

299

1.27

0.72

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

1.92

0.70

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.71

0.70

1.4

1.0

—

(3047181) Lactate [Moles/volume] in Blood

1017

0.86

0.69

4.4

6.7

1.28

1.26

mmol/l

0.15

890

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.68

6.0

2.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.53

0.68

1.6

2.3

21.38

18.27

umol/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

180

0.67

1.5

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.79

0.66

1.4

1.1

—

4.90

—

(3044007) Cell count panel - Peritoneal fluid

1.51

0.66

1.9

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

522

1.19

0.65

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.54

0.65

1.6

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.73

0.64

3.0

2.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

136

1219

1.12

0.63

2.1

1.6

7.68

3.64

mg/l

1.16

104

858

(3019060) Gas panel - Arterial blood

222

2043

1.09

0.62

5.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

208

1.30

0.62

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.60

0.61

1.6

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

601

1.17

0.60

3.5

3.1

0.77

0.82

nmol/l

0.63

452

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

209

1.29

0.60

1.3

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

150

0.67

0.58

1.6

3.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

689

1.15

0.57

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.67

0.56

1.3

5.82

5.66

mmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

212

1.28

0.55

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

431

1.19

0.54

1.6

1.4

4.92

4.08

ug/l

0.21

382

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.58

0.54

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.54

1.3

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.58

0.54

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

159

0.69

0.54

3.5

3.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

405

0.81

0.54

1.8

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.49

0.53

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.43

0.53

1.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

268

1.23

0.52

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

268

1.23

0.52

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

268

1.23

0.52

1.5

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

758

0.87

0.52

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

403

0.82

0.52

1.7

1.3

—

(40768806) Pleura Pathology biopsy report

323

1.21

0.52

1.8

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.50

0.51

1.3

1.0

—

(3005033) Fetal Nuchal fold Thickness US

686

1.14

0.51

1.4

—

(4211845)

168

0.71

0.50

1.5

3.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

243

1.24

0.49

1.9

1.5

0.91

0.96

g/l

0.52

243

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

216

1.25

0.49

5.7

6.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

400

0.82

0.49

1.8

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

410

0.83

0.48

1.7

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.40

0.48

1.5

1.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.40

0.48

1.8

2.1

9525.00

26438.81

e6/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

475

1.16

0.47

1.1

5.50

4.02

u/ml

0.24

192

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

398

0.83

0.47

1.8

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

398

0.83

0.47

1.8

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

164

1.28

0.46

1.1

1.3

180.00

230.54

pmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

826

1.12

0.46

1.5

1.4

—

(4015189)

1.43

0.45

2.7

2.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

496

1.15

0.45

1.3

1.2

77.10

41.22

u/l

0.69

426

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.37

0.44

5.0

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

636

6140

1.04

0.43

4.6

4.3

23.89

21.85

2.03

295

2976

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

830

1.11

0.43

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

830

1.11

0.43

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

239

1.21

0.42

2.7

2.4

784.21

610.77

0.95

165

(3017354) Segmented neutrophils/100 leukocytes in Blood

306

0.82

0.42

1.1

3.0

64.50

56.90

0.97

201

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

831

1.11

0.42

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

717

1.12

0.42

1.5

1.3

—

(3017732) Neutrophils [#/volume] in Blood

242

2280

1.07

0.42

2.3

3.0

3.96

4.08

e9/l

0.39

206

1795

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

345

3287

1.05

0.41

1.5

1.4

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

709

1.12

0.41

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.47

0.40

3.4

2.5

1.00

0.76

u/field

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

100

911

1.10

0.40

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.34

0.39

4.4

7.2

25.45

25.05

mmol/l

0.17

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

4.9

—

(44806071)

1.39

0.38

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

610

0.88

0.37

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.35

0.37

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.36

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

226

1.20

0.35

1.0

1.1

—

(3020891) Body temperature

132

1228

1.08

0.35

5.7

4.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.36

0.34

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

100

921

1.09

0.34

1.1

20.11

5.28

u/ml

0.45

111

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.33

0.33

4.7

2.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

145

1.24

0.33

1.2

1.0

88.56

93.59

0.33

109

(3020650) Glucose [Presence] in Urine

0.69

0.33

1.0

1.5

—

(3045788) Cell count panel - Pleural fluid

294

1.16

0.32

1.8

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.31

0.31

1.3

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

101

1.29

0.31

1.3

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

208

0.82

0.31

1.1

1.0

51.25

45.56

ng/l

0.22

135

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.30

0.30

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.31

0.30

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.30

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

206

0.82

0.29

1.1

1.0

745.67

713.30

ng/l

0.08

136

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

381

3683

1.04

0.28

1.8

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

197

1.17

0.25

1.8

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

135

1278

1.06

0.24

4.4

5.8

0.87

0.91

0.34

129

1194

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.24

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.32

0.23

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.74

0.22

1.0

1.1

—

4.47

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.16

0.21

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

1.24

0.21

1.3

1.1

—

(3022313) Gas panel - Capillary blood

161

1542

1.05

0.20

6.3

4.4

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.10

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

395

1.09

0.18

1.0

1.1

0.35

0.24

u/ml

0.16

107

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.13

0.18

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

134

1284

1.05

0.18

4.4

5.7

1.52

1.64

0.96

128

1196

(3004616) Nuclear Ab [Presence] in Serum

397

1.08

0.17

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.76

0.17

1.0

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.18

0.16

1.4

1.2

—

(3003129) Base excess in Capillary blood by calculation

0.77

0.15

1.5

1.8

0.93

0.92

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.76

0.15

3.0

7.6

—

(3012441) Differential panel - Pleural fluid

322

1.09

0.15

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.18

0.14

1.3

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

139

0.86

0.14

3.1

2.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.82

0.13

1.1

1.4

—

(3015183) Erythrocyte sedimentation rate

170

1.12

0.13

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

159

0.88

0.13

1.4

1.3

142.14

135.88

nmol/l

0.24

159

(3035933) Granulocytes/100 leukocytes in Blood

109

0.83

0.13

1.3

1.7

—

(40768800) Prostate Pathology biopsy report

478

0.94

0.12

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.11

1.3

1.1

—

(4024509)

332

0.93

0.11

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.14

0.10

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

135

0.89

0.09

1.5

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

135

0.89

0.09

2.3

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

135

0.89

0.09

1.5

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

1.13

0.09

1.4

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

412

0.95

0.09

1.8

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.15

0.09

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.77

0.08

2.2

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.04

0.08

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.05

0.07

2.5

3.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

204

0.93

0.07

1.2

1.1

—

(44806420)

0.89

0.06

2.8

2.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.84

0.06

2.5

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

356

0.95

0.06

1.1

—

2.89

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

415

1.04

0.05

1.3

6.44

7.38

mmol/l

1.89

310

(3020191) Ethanol [Moles/volume] in Serum or Plasma

238

1.05

0.05

1.6

1.4

1.71

1.18

promille

1.23

179

(3001019) Free T4 and TSH panel - Serum or Plasma

183

1807

1.01

0.05

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

333

0.96

0.05

1.6

1.4

157881.95

76026.43

e6/l

0.40

191

(3033799) Differential panel - Peritoneal fluid

1.10

0.04

2.0

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

163

1611

1.01

0.04

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

301

0.96

0.03

3.4

2.7

—

(3017704) Immunofixation for Urine

169

0.95

0.03

1.2

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

113

1.06

0.01

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

372

1.02

0.01

2.1

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

372

1.02

0.01

1.7

1.4

2511.32

1808.81

e6/l

0.58

267

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

119

1.01

0.00

2.3

1.7

16.14

14.48

pmol/l

—

100

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

561

1.00

0.00

1.9

1.7

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.92

0.00

1.0

1.1

—

7.51

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.09

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.38

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.97

0.00

1.2

1.3

3.21

3.18

mmol/l

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

2740.83

—

(4133840)

0.95

0.00

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1384.00

—

(3024869) Neuronal Ab [Presence] in Serum

1.02

0.00

1.2

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.7

—

0.22

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

38.60

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40757373) Influenza virus identified in Isolate

0.93

0.00

1.7

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

178.80

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.87

0.00

3.0

8.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT – Rash and other nonspecific skin eruption

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Rash and other nonspecific skin eruption

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Rash and other nonspecific skin eruption (R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints